Dark | Light
# ![@FWCStocks Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::151520851.png) @FWCStocks FWCStocks

FWCStocks posts on X about $tecx, $vera, $goss, $vtyx the most. They currently have [------] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.

### Engagements: [-----] [#](/creator/twitter::151520851/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::151520851/c:line/m:interactions.svg)

- [--] Week [-----] -63%
- [--] Month [------] +104%
- [--] Months [------] +15,098%
- [--] Year [------] -36%

### Mentions: [--] [#](/creator/twitter::151520851/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::151520851/c:line/m:posts_active.svg)

- [--] Month [--] -51%
- [--] Months [---] +6,233%
- [--] Year [---] +1,492%

### Followers: [------] [#](/creator/twitter::151520851/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::151520851/c:line/m:followers.svg)

- [--] Week [---] +0.67%
- [--] Month [---] +5.60%
- [--] Months [---] +18%
- [--] Year [---] +18%

### CreatorRank: [---------] [#](/creator/twitter::151520851/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::151520851/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  [finance](/list/finance)  [countries](/list/countries)  [currencies](/list/currencies)  [technology brands](/list/technology-brands)  [financial services](/list/financial-services)  [cryptocurrencies](/list/cryptocurrencies)  [travel destinations](/list/travel-destinations)  [social networks](/list/social-networks)  [celebrities](/list/celebrities) 

**Social topic influence**
[$tecx](/topic/$tecx), [$vera](/topic/$vera), [$goss](/topic/$goss), [$vtyx](/topic/$vtyx), [target](/topic/target), [$wve](/topic/$wve), [$annx](/topic/$annx), [$cccc](/topic/$cccc), [in the](/topic/in-the), [acquisition](/topic/acquisition)

**Top accounts mentioned or mentioned by**
[@amaymd](/creator/undefined) [@seedy19tron](/creator/undefined) [@biotechiq](/creator/undefined) [@pharmdca](/creator/undefined) [@jfais20](/creator/undefined) [@adamfeuerstein](/creator/undefined) [@pawcio2009](/creator/undefined) [@bioinvestor24](/creator/undefined) [@biotechnerd1](/creator/undefined) [@rnaianalyst](/creator/undefined) [@doepkemichel](/creator/undefined) [@bosstrading0](/creator/undefined) [@biotech2k1](/creator/undefined) [@avidresearch](/creator/undefined) [@tradeacct17](/creator/undefined) [@biostocks](/creator/undefined) [@andreagtc](/creator/undefined) [@stocksavvyshay](/creator/undefined) [@geneinvesting](/creator/undefined) [@themarketraven](/creator/undefined)

**Top assets mentioned**
[Vera Therapeutics, Inc. (VERA)](/topic/$vera) [Ventyx Biosciences, Inc. (VTYX)](/topic/$vtyx) [Wave Life Sciences Ltd. Ordinary Shares (WVE)](/topic/$wve) [Annexon, Inc. (ANNX)](/topic/$annx) [C4 Therapeutics, Inc (CCCC)](/topic/$cccc) [Eli Lilly and Company (LLY)](/topic/$lly) [Climb Bio, Inc (CLYM)](/topic/$clym) [Kyverna Therapeutics, Inc. (KYTX)](/topic/$kytx) [Synthetify (SNY)](/topic/$sny) [Sanofi (SNY)](/topic/sanofi) [BlackRock Inc (BLK)](/topic/blackrock) [Legend Biotech Corp (LEGN)](/topic/$legn) [Viking Holdings Ltd (VIK)](/topic/$vik) [AstraZeneca PLC (AZN)](/topic/$azn) [GSK plc (GSK)](/topic/$gsk) [Xilio Therapeutics, Inc. (XLO)](/topic/$xlo) [Adagene Inc. (ADAG)](/topic/$adag) [The 99% Community (99)](/topic/$99) [Uber Technologies, Inc. (UBER)](/topic/$uber) [SuperRare (RARE)](/topic/$rare)
### Top Social Posts
Top posts by engagements in the last [--] hours

"2026: I'm ONLY focusing on clinical stage biotechs that have catalysts in [----]. I think these companies will move the needle nicely. 85% return overall since June '25. My current slate: $ANNX $CCCC $CLYM $GOSS $KYTX $PALI $STRO $TECX $VERA. Sold $VTYX"  
[X Link](https://x.com/FWCStocks/status/2011253218240839935)  2026-01-14T01:45Z [---] followers, [---] engagements


"@jfais20 11/19: Wells Fargo raised the PT on $ANNX to $27 keeps it Overweight raises its POS to 55% that Phase [--] trial in GA will be positive in 2H26. Wells believes the it offers a significant asymmetric risk/reward skew with the potential for VC-like upside in the next [--] months"  
[X Link](https://x.com/FWCStocks/status/2008321191979700498)  2026-01-05T23:34Z [---] followers, [--] engagements


"$ANNX is Wells Fargo's #2 TOP PICK in SMID Cap Biotech behind $ARGX. Wells Fargo: We believe the [----] setup offers a significant asymmetric risk/reward with Venture Capital-like returns of more than 10x in the NTM. We expect shares to run up ahead of 2H data"  
[X Link](https://x.com/FWCStocks/status/2009486602851258766)  2026-01-09T04:45Z [---] followers, [---] engagements


"$ANNX 52-Week High. Wells Fargo #2 TOP PICK. We believe [----] offers a significant risk/reward with Venture Capital-like returns of more than 10x. Expect shares to run up ahead of 2H data. They present tomorrow at #JPM. Have you looked at this @Pharmdca @jfais20 @TheMarketRaven"  
[X Link](https://x.com/FWCStocks/status/2011101511770873968)  2026-01-13T15:42Z [---] followers, [---] engagements


"@jfais20 I'm focusing on clinical/pre-clinical stage biotechs that have catalysts this year or next. These companies will move the needle one way or the other. Up 75% overall since June '25. $ANNX $CCCC $CLYM $GOSS $KYTX $PALI $STRO $TECX $VERA. That's all of them for right now"  
[X Link](https://x.com/FWCStocks/status/2011251450635305294)  2026-01-14T01:38Z [---] followers, [---] engagements


"@jfais20 $ANNX 52-Week High today. Wells Fargo #2 TOP BIOTECH PICK. "We believe [----] offers a significant risk/reward with Venture Capital-like returns of more than 10x. Expect shares to run up ahead of 2H data". They present tomorrow at #JPM"  
[X Link](https://x.com/FWCStocks/status/2011275357551473041)  2026-01-14T03:13Z [---] followers, [--] engagements


"$LEGN ($17/sh): Partnership with JNJ. Consistent durable efficacy and particularly compelling outcomes for Carvykti when used in patients' multiple myeloma treatment journey. PTs: Barclays ($80) HCW ($50) Cowan ($26) Oppenheimer ($75) MS:($50). s https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-present-carvyktir-data-2026-tandem-meetings https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-present-carvyktir-data-2026-tandem-meetings"  
[X Link](https://x.com/anyuser/status/2020683857146544563)  2026-02-09T02:19Z [---] followers, [---] engagements


"$TECX: Management buy $175000 of stock on the open market"  
[X Link](https://x.com/FWCStocks/status/2022959617647714489)  2026-02-15T09:02Z [---] followers, [--] engagements


"#HURRICANE Florence weakens to Cat [--] storm but storm surge expected to hit catastrophic levels #FWCWeather http://gpwx.news/sf18j http://gpwx.news/sf18j"  
[X Link](https://x.com/FWCStocks/status/1040084228241862656)  2018-09-13T03:46Z [---] followers, [--] engagements


"Thousands are evacuated as monster #HURRICANE Willa descends on Mexico #FWCWeather http://gpwx.news/rx2bm http://gpwx.news/rx2bm"  
[X Link](https://x.com/FWCStocks/status/1054681834351718400)  2018-10-23T10:31Z [---] followers, [--] engagements


"Iran puts death toll from #FLOODING at [--] #FWCWeather http://gpwx.news/5473k http://gpwx.news/5473k"  
[X Link](https://x.com/FWCWeather/status/1113456722419560448)  2019-04-03T15:02Z [---] followers, [--] engagements


"@StockSavvyShay I think you should look into $ADAG $CCCC $TECX and $VTYX. You're welcome"  
[X Link](https://x.com/FWCWeather/status/1975327858584379567)  2025-10-06T22:30Z [---] followers, [----] engagements


"@Pharmdca Hard pass"  
[X Link](https://x.com/FWCWeather/status/1978547557698576535)  2025-10-15T19:44Z [---] followers, [--] engagements


"Flights wont be leaving from Montego Bay for quite some time. OMG. Sangster International Airport Mashup in Montego mash up Posted by https://t.co/g1OkuSko5T https://t.co/LS446qaduz OMG. Sangster International Airport Mashup in Montego mash up Posted by https://t.co/g1OkuSko5T https://t.co/LS446qaduz"  
[X Link](https://x.com/FWCWeather/status/1983415506884612419)  2025-10-29T06:08Z [---] followers, [---] engagements


"@pawcio2009 @seedy19tron @A_May_MD @trade_acct_17 $VTYX: Catalyst [--] - VTX3232 results were positive and had surprisingly good results. Sanofi has right to first refusal to partner with VTYX and should happen anytime. Catalyst 2: A huge Ph2 readout (4Q25) for VTX2735 for Recurrent Pericarditis should rocket VTYX much higher"  
[X Link](https://x.com/FWCWeather/status/1984952593634746646)  2025-11-02T11:55Z [---] followers, [---] engagements


"@pawcio2009 @seedy19tron @A_May_MD @trade_acct_17 $VERA: Financials this week. This one is going to see an enormous run on its Ph2 readout. VERA is disease-modifying. Theyll be filing a BLA with accelerated approval soon"  
[X Link](https://x.com/FWCWeather/status/1984955019158868074)  2025-11-02T12:05Z [---] followers, [---] engagements


"@cigs1234 Pretty sure you should look at $WVE a slew of surprising findings and how their drug helps patients with liver damage. I think it was so surprising that they created a new drug trial for it WAVE-008 (among numerous other collabs and studies they have going on)"  
[X Link](https://x.com/FWCWeather/status/1984974306527400385)  2025-11-02T13:22Z [---] followers, [---] engagements


"@Pharmdca MSNBC article today: The China acquisition and other smaller players raised questions about the fate of U.S. obesity biotechs like Viking Therapeutics which were once hot takeover targets. Some argue their drugs havent differentiated themselves enough from existing treatments"  
[X Link](https://x.com/FWCWeather/status/1985091533998027207)  2025-11-02T21:07Z [---] followers, [---] engagements


"@bioinvestor24 MSNBC article today: The China acquisition and other smaller players raised questions about the fate of U.S. obesity biotechs like Viking Therapeutics which were once hot takeover targets. Some argue their drugs havent differentiated themselves enough from existing treatments"  
[X Link](https://x.com/FWCWeather/status/1985091576775733661)  2025-11-02T21:08Z [---] followers, [--] engagements


"@bioinvestor24 MSNBC article today: The China acquisition and other smaller players raised questions about the fate of U.S. obesity biotechs like Viking Therapeutics which were once hot takeover targets. Some argue their drugs havent differentiated themselves enough from existing treatments"  
[X Link](https://x.com/FWCWeather/status/1985091786180591768)  2025-11-02T21:08Z [---] followers, [---] engagements


"@bioinvestor24 https://www.cnbc.com/2025/11/02/whats-next-for-the-weight-loss-drug-market-pills-rivals-insurance.html https://www.cnbc.com/2025/11/02/whats-next-for-the-weight-loss-drug-market-pills-rivals-insurance.html"  
[X Link](https://x.com/FWCWeather/status/1985092066271997978)  2025-11-02T21:10Z [---] followers, [--] engagements


"@bioinvestor24 https://www.cnbc.com/2025/11/02/whats-next-for-the-weight-loss-drug-market-pills-rivals-insurance.html https://www.cnbc.com/2025/11/02/whats-next-for-the-weight-loss-drug-market-pills-rivals-insurance.html"  
[X Link](https://x.com/FWCWeather/status/1985092091635208682)  2025-11-02T21:10Z [---] followers, [--] engagements


"@Pharmdca https://www.cnbc.com/2025/11/02/whats-next-for-the-weight-loss-drug-market-pills-rivals-insurance.html https://www.cnbc.com/2025/11/02/whats-next-for-the-weight-loss-drug-market-pills-rivals-insurance.html"  
[X Link](https://x.com/FWCWeather/status/1985092138527330781)  2025-11-02T21:10Z [---] followers, [--] engagements


"My Sunday night excitement.watching this video. How long does it take for him to get out This was captured on I-40 in Arkansas during a snowstorm https://t.co/N10O9MON0N How long does it take for him to get out This was captured on I-40 in Arkansas during a snowstorm https://t.co/N10O9MON0N"  
[X Link](https://x.com/FWCWeather/status/1987803211600703640)  2025-11-10T08:43Z [---] followers, [--] engagements


"I always thought about the extremely rare chance that a plane could collide with a weather balloon but never actually heard of it happening before. https://nypost.com/2025/11/22/us-news/weather-balloon-shattered-windshield-of-united-airlines-flight-36000-feet-over-utah-ntsb/utm_social_handle_id=134486075205&utm_medium=social&sr_share=facebook&utm_campaign=nypost&utm_source=facebook&utm_social_post_id=590403776&utm_medium=social&utm_campaign=nypost&utm_source=facebook&sr_share=fa"  
[X Link](https://x.com/FWCWeather/status/1992704474981540263)  2025-11-23T21:19Z [---] followers, [--] engagements


"@Biotechnerd1 $VERA: I added on the stupid panic selloff after hours last night"  
[X Link](https://x.com/FWCWeather/status/1993720168586064262)  2025-11-26T16:35Z [---] followers, [--] engagements


"Amazing opportunity to buy $VERA. Otuska received the 1st FDA Approval for IGAN yesterday. $VERA has even better EGFR numbers and similar reduction in protein in urine. CANTOR: Reiterates $100 PT HC Wainwright: $90 PT Wells Fargo: $70 PT @seedy19tron @BioStocks @Pharmdca"  
[X Link](https://x.com/FWCWeather/status/1993723499966521800)  2025-11-26T16:48Z [---] followers, [---] engagements


"@A_May_MD: Wells Fargo Note this evening: In our follow-up with mgmt they highlighted this was more logistics than anything and permits the ability to introduce QD dose ranging into pts sooner ahead of a planned Ph3 in 2H26 vs. looking at QD later. More"  
[X Link](https://x.com/FWCWeather/status/1996047489414095264)  2025-12-03T02:43Z [---] followers, [--] engagements


"$VTYX: Wells Fargo note this evening: In our follow-up with mgmt they highlighted this was more logistics than anything and permits the ability to introduce QD dose ranging into pts sooner ahead of a planned Ph3 in 2H26 vs. looking at QD later. More @A_May_MD"  
[X Link](https://x.com/FWCStocks/status/1996048062893187229)  2025-12-03T02:45Z [---] followers, [---] engagements


"@MartinShkreli You might get sued for slander or libel"  
[X Link](https://x.com/FWCWeather/status/1996265645890257302)  2025-12-03T17:09Z [---] followers, [---] engagements


"BREAKING (part 1): $VERA's going to be a blockbuster From today's CITI Healthcare Conference: -KDIGO's next release of kidney disease guidelines is planned around expected approval of Atacicept in July '26. @_Biotech_iQ @A_May_MD @adamfeuerstein @seedy19tron @Biotechnerd1"  
[X Link](https://x.com/FWCWeather/status/1996332762391818640)  2025-12-03T21:36Z [---] followers, [---] engagements


"BREAKING (part 2): $VERA From today's CITI Healthcare Conference: --VERA identified [--] additional autoimmune indications outside of kidney disease that Atacicept would have successful clinical outcomes. @_Biotech_iQ @A_May_MD @adamfeuerstein @seedy19tron @Biotechnerd1"  
[X Link](https://x.com/FWCWeather/status/1996333332985249957)  2025-12-03T21:38Z [---] followers, [---] engagements


"$VERA: JP Morgan: Price Target raised to $99 from $52. 7:00 PM 12/3/25. Updated model following multiple competitive updates for sibeprenlimab. With market dynamics & TAM JPM sees the product as strategically attractive. @_Biotech_iQ @A_May_MD @adamfeuerstein @seedy19tron"  
[X Link](https://x.com/FWCWeather/status/1996373293033800031)  2025-12-04T00:17Z [---] followers, [---] engagements


"@BillAckman @Uber @dkhos Blast them with emails Executive Emails Dara Khosrowshahi (CEO): khosrowshahid@uber.com Troy Stevenson (Global Head of Customer Operations): stevensont@uber.com (or TroyS@uber.com on LinkedIn) Tomasz Krawczyk (Senior Director Community Operations): krawczykt@uber.com"  
[X Link](https://x.com/FWCWeather/status/1997331023953035553)  2025-12-06T15:43Z [---] followers, [---] engagements


"@_Biotech_iQ VTYX looks quite superior from this data. I am long $VTYX because they also have several significant readouts coming (VTX 2735).not to mention a decision by Sanofi to partner on VTYX [----] by January [----] (estimate per Wells Fargo)"  
[X Link](https://x.com/FWCWeather/status/1997794547808768166)  2025-12-07T22:25Z [---] followers, [---] engagements


"@Andre_AGTC VTYX is awaiting a decision on Sanofi which has the right of first refusal to partner the drug.or maybe outright acquire them. A decision by Sanofi is expected in the next [--] days or so per Wells Fargo. Conference calls suggest they have other partners waiting in the wings"  
[X Link](https://x.com/FWCWeather/status/1997804699513483502)  2025-12-07T23:05Z [---] followers, [---] engagements


"@Andre_AGTC @grok VTYX is likely to get a partnership or acquisition by Sanofi or another large pharma company by the end of January (or sooner). Sanofi has the right of first refusal. Share price is going to start jumping on anticipation now"  
[X Link](https://x.com/FWCWeather/status/1998108765690933516)  2025-12-08T19:13Z [---] followers, [--] engagements


"$SNTI: 12/9/25-Leerink Partners initiated coverage with a Outperform rating & a $6.00 price target. Positive Phase [--] clinical data for SENTI-202 presented at ASH showed a 50% ORR and 42% complete remission rate in relapsed/refractory acute myeloid leukemia. @A_May_MD @semodough"  
[X Link](https://x.com/FWCStocks/status/1998430432631861508)  2025-12-09T16:31Z [---] followers, [---] engagements


"@RNAiAnalyst 12/12: Wedbush raises price target on Wave Life Sciences adds to Best Ideas List Wedbush analyst Yun Zhong added Outperform-rated Wave Life Sciences to the firm's Best Ideas List and raised the price target on the stock to $33 from $20"  
[X Link](https://x.com/FWCWeather/status/1999448739069730821)  2025-12-12T11:58Z [---] followers, [----] engagements


"@BiotechAnalysst $STRO this morning: Sutro Biopharma PT raised to $51 from $5 at Deutsche Bank and keeps a Buy rating on the shares. The company's STRO-004 is entering the Clinic while its dual payload antibody-drug conjugates will emerge in [----] the analyst tells investors in a research note"  
[X Link](https://x.com/FWCStocks/status/2001295376326754813)  2025-12-17T14:16Z [---] followers, [---] engagements


"@BioStocks $STRO this morning: Sutro Biopharma PT raised to $51 from $5 at Deutsche Bank and keeps a Buy rating on the shares. The company's STRO-004 is entering the Clinic while its dual payload antibody-drug conjugates will emerge in [----] the analyst tells investors"  
[X Link](https://x.com/FWCStocks/status/2001295729076097319)  2025-12-17T14:17Z [---] followers, [--] engagements


"$STRO: Sutro Biopharma price target raised to $51 from $5 at Deutsche Bank. Deutsche Bank keeps a Buy rating on the shares. The company's STRO-004 is entering the Clinic while its dual payload antibody-drug conjugates will emerge in [----] the analyst tells investors"  
[X Link](https://x.com/FWCStocks/status/2001315236645622014)  2025-12-17T15:35Z [---] followers, [--] engagements


"Also started a large position in $GOSS"  
[X Link](https://x.com/FWCStocks/status/2001413162059346230)  2025-12-17T22:04Z [---] followers, [---] engagements


"$TECX: Expecting a big AZN3427 readout within the next week that will have major implications on TX45 and TECX. WELLS FARGO: Stock moves 25%+ higher on a positive AZN3427 update by end of [----] with a 5-10x move in share price on positive TX45-Ph2 APEX study readout in 2026"  
[X Link](https://x.com/FWCStocks/status/2002037979532116375)  2025-12-19T15:27Z [---] followers, [---] engagements


"$WVE: Price target raised to $30 from $22 at H.C. Wainwright. Part [--] of [--]. The firm says its key opinion leader and dose-response modeling confirm WVE-007 as a potential "body recomposition" agent delivering 9.4% visceral fat loss and 3.2% lean mass gain with zero GI issues"  
[X Link](https://x.com/FWCStocks/status/2002044260355653789)  2025-12-19T15:52Z [---] followers, [---] engagements


"Part 2/3: Experts identify significant unmet need and add-on to GLP-1s solving the issues of visceral adiposity muscle loss and weight rebound. Higher doses and a clean safety profile will accelerate fat loss to competitive levels and a differentiated commercial label"  
[X Link](https://x.com/FWCStocks/status/2002045184335335536)  2025-12-19T15:55Z [---] followers, [--] engagements


"$VERA $VTYX $WVE and $TECX are my highest confidence stocks for [----]. $VERA will be a $95+ stock after FDA approval. ($VERA indicated on a call that their results showed stable and even improved eGFR opens the door for many new indications. Think ACQUISITION TARGET)"  
[X Link](https://x.com/FWCStocks/status/2002049995239981502)  2025-12-19T16:14Z [---] followers, [---] engagements


"@A_May_MD $AZN is supposed to have a readout for AZN3427 with a big readthrough for TECXs TX45 drug. Wells Fargo saying TECX could be +25% on AZNs readout and a 5-10x run for TECX if the TX45 readout is favorable next year"  
[X Link](https://x.com/FWCStocks/status/2003668065385611308)  2025-12-24T03:24Z [---] followers, [---] engagements


"Merry Christmas from the Turks and Caicos Islands"  
[X Link](https://x.com/FWCStocks/status/2004311413368803753)  2025-12-25T22:00Z [---] followers, [---] engagements


"$GSK purchases [-------] shares of $WVE on 12/15/25 at $19 per share (valued at $27.93 million)increasing GSKs total beneficial ownership to [--------] shares (about 14.8% of WVEs outstanding shares). ACQUISITION TARGET for 2026"  
[X Link](https://x.com/FWCStocks/status/2005249996967575881)  2025-12-28T12:10Z [---] followers, [---] engagements


"Goodbye Ilhan Omar You see that glow flashing in the corner of your eye That's your career dissipation light. It just went into high gear." @elonmusk https://nypost.com/2025/12/27/us-news/ilhan-omars-hubbys-30m-firm-quietly-scrubs-names-from-website-as-squad-member-faces-mounting-questions-on-sudden-wealth-amid-minnesota-welfare-fraud/ https://nypost.com/2025/12/27/us-news/ilhan-omars-hubbys-30m-firm-quietly-scrubs-names-from-website-as-squad-member-faces-mounting-questions-on-sudden-wealth-amid-minnesota-welfare-fraud/"  
[X Link](https://x.com/FWCStocks/status/2005482550547161296)  2025-12-29T03:34Z [---] followers, [--] engagements


"$RARE. JP Morgan had a terrible forecast from 10/12/25. JPMorgan analyst Anupam Rama: [--]. Placed RARE on "Positive Catalyst Watch" ahead of ORBIT & COSMIC study updates. [--]. Confidence in setrusumab's success with a PT of &125. [--]. Sees a "very positive" reward/risk profile"  
[X Link](https://x.com/FWCStocks/status/2005645976812622057)  2025-12-29T14:23Z [---] followers, [---] engagements


"@RNAiAnalyst Im sitting out the ABVX hype machine. Not worth it to me. If M&A doesnt happen the selloff will be significant"  
[X Link](https://x.com/FWCStocks/status/2005981153883517202)  2025-12-30T12:35Z [---] followers, [---] engagements


"Recall $SNY has the first right of refusal to partner with (or flat out acquire) $VTYX. Wells Fargo predicts that this should happen before the end of January based on their research of other acquisitions"  
[X Link](https://x.com/FWCStocks/status/2006039256741924923)  2025-12-30T16:26Z [---] followers, [---] engagements


"$CLYM FILES SEC COMPLAINT AGAINST ALUMIS $ALMS AND ACELYRIN RELATING TO A DISPUTE CONCERNING A PURCHASE AGREEMENT DATED JANUARY [--] [----]. CLYM SEEKS DECLARATORY JUDGMENT THAT CO'S BUDOPRUTUG DRUG CANDIDATE IS NOT "PRODUCT" AND IT DOES NOT OWE A MILESTONE PAYMENT SOUGHT BY $ALMS"  
[X Link](https://x.com/FWCStocks/status/2006513285705953761)  2025-12-31T23:50Z [---] followers, [---] engagements


"$ANNX is Wells Fargo's #2 TOP PICK in SMID Cap Biotech behind $ARGX. Wells Fargo: We believe the [----] setup offers a significant asymmetric risk/reward with Venture Capital-like returns of more than 10x in the NTM. We expect shares to run up ahead of 2H data"  
[X Link](https://x.com/FWCStocks/status/2007093029199642920)  2026-01-02T14:14Z [---] followers, [---] engagements


"@RNAiAnalyst Agreed. Long and strong. ARWR just made the case for $WVE"  
[X Link](https://x.com/FWCStocks/status/2008527706929992114)  2026-01-06T13:14Z [---] followers, [---] engagements


"$WVE was the first to the party with the results. Expecting several upgrades for $WVE based on the confirmational data from $ARWR this morning. $WVE will be a strong buyout candidate this year because of WVE-007 Aatd and possible even their HD drug"  
[X Link](https://x.com/FWCStocks/status/2008529697374933145)  2026-01-06T13:22Z [---] followers, [---] engagements


"Im up 150% on my $WVE investment. Everything I own is playing with the banks money right now. Yet even with $WVE up 24% pre-market on $ARWRs news I see no reason to scale back my position/take more profits given the huge potential $WVE has. Do you agree or disagree"  
[X Link](https://x.com/FWCStocks/status/2008532189135421556)  2026-01-06T13:32Z [---] followers, [---] engagements


"@adamfeuerstein Wells Fargo valued $VTYX at $25/share if VTX2735 and VTX3232 was partnered.let alone bought out. That's would be an additional 75% gain from current after-hours levels"  
[X Link](https://x.com/FWCStocks/status/2008648446279053360)  2026-01-06T21:14Z [---] followers, [----] engagements


"What stock price do you think $VTYX will settle at with an $LLY purchase $LLY in final talks to buy $VTYX Wells Fargo valued $VTYX at $25/share if VTX2735 and VTX3232 was partnered.let alone bought out. That's would be an additional 75% gain from current after-hours levels"  
[X Link](https://x.com/FWCStocks/status/2008649787298771120)  2026-01-06T21:20Z [---] followers, [---] engagements


"@PersimmonTI I finally got my first M&A. Bought at $4. Up 306% due to some selling high and buying low I did in the past [--] months. Still holding as I think the buyout price would make $VTYX in the $20-$25 range"  
[X Link](https://x.com/FWCStocks/status/2008671415839637883)  2026-01-06T22:45Z [---] followers, [---] engagements


"@_Biotech_iQ $LLY knows $VTYX is on to big things. If multiple outlets are reporting the buyout rumor like the WSJ says.then it's going to happen. To your point I also did not sell any shares after hours because I think the deal could be well over $1B (with a $VTYX value of $20-25+/share)"  
[X Link](https://x.com/FWCStocks/status/2008696297763520844)  2026-01-07T00:24Z [---] followers, [---] engagements


"@_Biotech_iQ 11/5/25: HC Wainwright: "Recent data from Ventyx's VTX3232 Phase [--] trial for obesity and cardiovascular risk "largely mimics" data presented from IL-6 inhibitor pacibekitug from Tourmaline which was acquired by Novartis for $1.4B in September""  
[X Link](https://x.com/FWCStocks/status/2008701551964045513)  2026-01-07T00:45Z [---] followers, [--] engagements


"Looks like $LLY flew to London not for a deal with $ABVX but because theyve been working on opening a new biotech development hub there. https://www.fiercebiotech.com/biotech/weight-loss-windfall-lilly-looks-become-backbone-global-innovation https://www.fiercebiotech.com/biotech/weight-loss-windfall-lilly-looks-become-backbone-global-innovation"  
[X Link](https://x.com/FWCStocks/status/2008754914931933427)  2026-01-07T04:17Z [---] followers, [---] engagements


"More ammo supporting the $LLY / $VTYX buyout rumor in this LinkedIn post where the $VTYX CEO congratulates $LLYs new Director of Corporate Business Development who discusses $LLYs aggressive Business Development interests"  
[X Link](https://x.com/FWCStocks/status/2008757888416969017)  2026-01-07T04:29Z [---] followers, [---] engagements


"$VTYX: I'm not convinced there won't be a bidding war $SNY has the Right of First Refusal yet reports say $LLY is the poss. acquirer. Doesn't make complete sense why $SNY would drop it. The $14 rumored price may be too low. Keep in mind: Wells Fargo PT is $25 and UBS PT is $20"  
[X Link](https://x.com/FWCStocks/status/2008958528610775321)  2026-01-07T17:46Z [---] followers, [--] engagements


"@doepke_michel $VTYX: I'm not convinced there won't be a bidding war $SNY has the Right of First Refusal yet reports say $LLY is the poss. acquirer. Doesn't make complete sense why $SNY would drop it. The $14 rumored price may be too low. Keep in mind: Wells Fargo PT is $25 and UBS PT is $20"  
[X Link](https://x.com/FWCStocks/status/2008958651029925942)  2026-01-07T17:47Z [---] followers, [---] engagements


"@BOSSTRADING0 @ChartsRUs0 $VTYX: I'm not convinced there won't be a bidding war $SNY has the Right of First Refusal yet reports say $LLY is the poss. acquirer. Doesn't make complete sense why $SNY would drop it. The $14 rumored price may be too low. Keep in mind: Wells Fargo PT is $25 and UBS PT is $20"  
[X Link](https://x.com/FWCStocks/status/2008959024545583521)  2026-01-07T17:48Z [---] followers, [---] engagements


"@RNAiAnalyst $VTYX: I'm not convinced there won't be a bidding war $SNY has the Right of First Refusal yet reports say $LLY is the poss. acquirer. Doesn't make complete sense why $SNY would drop it. The $14 rumored price may be too low. Keep in mind: Wells Fargo PT is $25 and UBS PT is $20"  
[X Link](https://x.com/FWCStocks/status/2008959160126476703)  2026-01-07T17:49Z [---] followers, [---] engagements


"Struggling with $ED Theres no pill to tell you when to buy or sell. 😂😂😂"  
[X Link](https://x.com/FWCStocks/status/2009433831254983019)  2026-01-09T01:15Z [---] followers, [--] engagements


"@Biotech2k1 Youre the only one who posts daily about how you want to sell and that theres a biotech bubble. I see this from nobody else and instead theses and risk are based on expected growth and development of their products"  
[X Link](https://x.com/FWCStocks/status/2010713169518375416)  2026-01-12T13:59Z [---] followers, [---] engagements


"The $VERA PDUFA will be close to the new PDUFA date for $TVTX. $VERA presents this afternoon at #JPM. $VERA has a very high likelihood of approval is a much better company to own and share price should at least double (see numerous Price Targets) leading up to/after approval"  
[X Link](https://x.com/FWCStocks/status/2011151266068775196)  2026-01-13T19:00Z [---] followers, [---] engagements


"-Sales reps initially targeting [----] nephrologists. -More results later this year about targeting other autoimmune diseases. -More trial data coming at ERA in June. -$779M in cash. $425M additional non-dilutive avail"  
[X Link](https://x.com/FWCStocks/status/2011211544345096215)  2026-01-13T22:59Z [---] followers, [--] engagements


"@BOSSTRADING0 UBS upgraded $GOSS to Buy with a price target of $9. Views the risk/reward as "compelling" into the Ph [--] pulmonary arterial hypertension data in February [----]. Probability of success is underappreciated and seralutinib offers a "differentiated" mechanism of action"  
[X Link](https://x.com/FWCStocks/status/2011277032253243437)  2026-01-14T03:19Z [---] followers, [---] engagements


"@doepke_michel Interesting by year-end 2026: -Earn research milestones/licensing fees from collaborations with Merck KGaA Darmstadt Germany Roche and Biogen. -Deliver at least one development candidate to a collaboration partner. -Advance existing collaborations toward key milestones"  
[X Link](https://x.com/FWCStocks/status/2011421842662416523)  2026-01-14T12:55Z [---] followers, [--] engagements


"$PALI: Buying the selloff. 1) Phase 1b data for PALI-2108 in fibrostenotic Crohn's disease (FSCD) expected in (Q1 2026). Topline safety pharmacokinetics (PK) and pharmacodynamics (PD) data. 2) The Crohn's & Colitis Foundation just made a $500000 investment in $PALI"  
[X Link](https://x.com/FWCStocks/status/2012201810367312366)  2026-01-16T16:34Z [---] followers, [----] engagements


"@diamondguyizzy There was a run-up and peak at the end of December when they were granted a patent by Japan for PALI-2108. I think this one is under the radar. Hence why I am slowly building my position"  
[X Link](https://x.com/FWCStocks/status/2012203047531716744)  2026-01-16T16:39Z [---] followers, [---] engagements


"$PALI today announced that two abstracts highlighting its lead program PALI-2108 have been selected for presentation at two premier international inflammatory bowel disease (IBD) meetings in early 2026"  
[X Link](https://x.com/FWCStocks/status/2012204208573788169)  2026-01-16T16:44Z [---] followers, [---] engagements


"@Albrtspain Piper Sandler initiated coverage of $PALI with an Overweight rating and $25 price target. Piper says Palisade "is a great name to own" ahead of PALI-2108's Phase1b fibrostenotic Crohn's disease data in Q1. The shares are undervalued considering that PDE4 inhibition is validated"  
[X Link](https://x.com/FWCStocks/status/2012381303262310707)  2026-01-17T04:27Z [---] followers, [---] engagements


"@pawcio2009 Next up $PALI. +12% pop today on no news"  
[X Link](https://x.com/FWCStocks/status/2013721530497147110)  2026-01-20T21:13Z [---] followers, [---] engagements


"Nothing says upcoming failed drug trial like a press release at [--] pm on a Friday announcing upcoming results on Monday Okay okay well see but just wondering. $SRPT"  
[X Link](https://x.com/FWCStocks/status/2014838992378724676)  2026-01-23T23:13Z [---] followers, [---] engagements


"(2) LLY was ultimately the only bidder on VTYX despite SNY and another large pharma company conducting advanced due diligence although negotiations with LLY coincided with holiday recesses for SNY and Party A"  
[X Link](https://x.com/FWCStocks/status/2015491111570096541)  2026-01-25T18:25Z [---] followers, [--] engagements


"Recall in Sep [----] SNY invested $27M into VTYX and received a right of first negotiation (ROFN) on VTYX's CNS-penetrant NLRP3 inhibitor VTX3232. The negotiation period of the ROFN was to open after VTYX shared obesity data for '3232 in Oct 2025"  
[X Link](https://x.com/FWCStocks/status/2015491208663990448)  2026-01-25T18:25Z [---] followers, [--] engagements


"VTYX contacted [--] biopharmaceutical companies (including LLY and SNY). Of these [--] did not express interest [--] expressed interest in a license of '3232 for neurological indications alone [--] conducted preliminary due diligence but did not pursue"  
[X Link](https://x.com/FWCStocks/status/2015491351668768864)  2026-01-25T18:25Z [---] followers, [--] engagements


"2 conducted initial due diligence but required additional clinical data and three (LLY SNY and another large pharma company referred to as Party A) entered advanced due diligence"  
[X Link](https://x.com/FWCStocks/status/2015491424049906118)  2026-01-25T18:26Z [---] followers, [--] engagements


"VTYX representatives contacted Party A on Dec [--] and SNY on Dec [--] to inform them VTYX had received an acquisition proposal. Party A stated their due diligence was ongoing and they were unlikely to accelerate any deliberations over the holidays"  
[X Link](https://x.com/FWCStocks/status/2015491539934347699)  2026-01-25T18:26Z [---] followers, [--] engagements


"The representative of VTYX did not respond due to the ongoing exclusivity agreement. On Jan [--] VTYX and LLY signed and announced the merger agreement"  
[X Link](https://x.com/FWCStocks/status/2015491782004416960)  2026-01-25T18:27Z [---] followers, [--] engagements


"President Trump calls #HURRICANE Irma some big monster #FWCWeather http://gpwx.news/0rmwv http://gpwx.news/0rmwv"  
[X Link](https://x.com/FWCStocks/status/907042551290634240)  2017-09-11T00:46Z [---] followers, [--] engagements


"$XLO: You might want to look at this one -$17.5M milestone achieved with Gilead -Abbvie and Xilio Collab: Xilio receives $52.0M in upfront payments $10.0M equity investment. Eligible for $2.1B in fees milestones royalties. @StockSavvyShay https://finance.yahoo.com/news/xilio-therapeutics-announces-upcoming-presentations-130000244.html https://finance.yahoo.com/news/xilio-therapeutics-announces-upcoming-presentations-130000244.html"  
[X Link](https://x.com/FWCStocks/status/1975566933882978577)  2025-10-07T14:20Z [---] followers, [---] engagements


"@pawcio2009 @seedy19tron @A_May_MD @trade_acct_17 Others to watch these week: $CLYM $XLO $QURE $VTYX"  
[X Link](https://x.com/FWCStocks/status/1984955281047015569)  2025-11-02T12:06Z [---] followers, [---] engagements


"$VERA +13% today going +100-200% next few months. VERY confident. Jim Meyers former E.V.P of Gilead named to VERA's Board of Directors today. VERA submitted BLA with Accelerated Approval to FDA. [--] conferences next week. @seedy19tron @BioStocks @Pharmdca https://finance.yahoo.com/news/vera-therapeutics-appoints-veteran-biotech-210500545.html https://finance.yahoo.com/news/vera-therapeutics-appoints-veteran-biotech-210500545.html"  
[X Link](https://x.com/FWCStocks/status/1993821940558319731)  2025-11-26T23:19Z [---] followers, [--] engagements


"$VERA Presents on 12/2/25 at the Evercore Healthcare Conference. $CLYM Presents on 12/2/25 at the Piper Sandler Healthcare Conference. $CCCC Presents on 12/3/25 at the Evercore Healthcare Conference. $VERA Presents on 12/3/25 at the Citi Healthcare Conference"  
[X Link](https://x.com/FWCStocks/status/1995646539826606374)  2025-12-02T00:09Z [---] followers, [---] engagements


"Biotech LONG's should really check out the following companies. A great day today: $STRO: +20% $CCCC: +14% $MGX: +14% $VERA: +13% @_Biotech_iQ @dough @A_May_MD @adamfeuerstein @seedy19tron @Biotechnerd1"  
[X Link](https://x.com/FWCStocks/status/1996327867060224447)  2025-12-03T21:17Z [---] followers, [---] engagements


"Money flowing in from AI/Tech to Biotech which is why the XBI is not falling like other indexes. Biotech will rebound very soon. $KYTX Started a large position on the stupid selloff. $CCCC: Added shares $STRO: Added shares $ACET: Added shares $WVE: Added/Doubled my Shares"  
[X Link](https://x.com/FWCStocks/status/2001412949064192320)  2025-12-17T22:03Z [---] followers, [---] engagements


"$VERA: All-time high of $51.72 reached today on the heals of several analyst upgrades this morning. JP Morgan: Upgrade to $96/share Goldman Sachs: Upgrade to $95/share BofA: Upgrade to $66/share Numerous other upgrades in the past few weeks with PT's generally $80-$100/share"  
[X Link](https://x.com/FWCStocks/status/2002083658132516869)  2025-12-19T18:28Z [---] followers, [---] engagements


"$KYTX: A Director and a fund buy over [------] shares of the stock on the open market a few days ago. Very bullish"  
[X Link](https://x.com/FWCStocks/status/2003425432776147272)  2025-12-23T11:20Z [---] followers, [---] engagements


"@doepke_michel No mention of $VERA $VTYX or $WVE Most of these are on my list with much higher probabilities of acquisition than the ones you list here IMO"  
[X Link](https://x.com/FWCStocks/status/2005357107189784608)  2025-12-28T19:16Z [---] followers, [----] engagements


"Been taking advantage of some year-end profit-taking (selling) to add to a few of my positions with $CCCC $CLYM $TECX $VERA and $GOSS. Fully expecting biotech stocks to come roaring back after January 1"  
[X Link](https://x.com/FWCStocks/status/2006038552451183068)  2025-12-30T16:23Z [---] followers, [---] engagements


"@BOSSTRADING0 $VERA $TECX $STRO and $CLYM"  
[X Link](https://x.com/FWCStocks/status/2006897675891863878)  2026-01-02T01:17Z [---] followers, [---] engagements


"@doepke_michel $VERA"  
[X Link](https://x.com/FWCStocks/status/2007224771759747461)  2026-01-02T22:57Z [---] followers, [---] engagements


"@Biotenic @Biotenic the $VERA PDUFA is expected around July or so"  
[X Link](https://x.com/FWCStocks/status/2007989027740545171)  2026-01-05T01:34Z [---] followers, [---] engagements


"$VTYX halted $LLY in advanced talks to buy Ventyx Biosciences in more than $1 billion deal WSJ reports"  
[X Link](https://x.com/FWCStocks/status/2008644305926381643)  2026-01-06T20:58Z [---] followers, [---] engagements


"@Biotech2k1 $TECX $ANNX"  
[X Link](https://x.com/FWCStocks/status/2008709709742960696)  2026-01-07T01:18Z [---] followers, [---] engagements


"$ANNX: +14% today so far"  
[X Link](https://x.com/FWCStocks/status/2011164548506796327)  2026-01-13T19:52Z [---] followers, [--] engagements


"$CCCC: +10% today so far"  
[X Link](https://x.com/FWCStocks/status/2011164944067412373)  2026-01-13T19:54Z [---] followers, [--] engagements


"$VERA Highlights from #JPM26. (part 1) -PDUFA date 7/7/26. Priority review awarded. -Investigating atacicept in [--] other diseases -1st Dual BAFF/APRIL inhibitor. -Drug stopped Kidney Function/EGFR Slope decline. -Sales Leadership in place. Now hiring [--] sales reps"  
[X Link](https://x.com/FWCStocks/status/2011210864796598336)  2026-01-13T22:56Z [---] followers, [---] engagements


"You should check out this presentation when it's posted @Biotech2k1 @BOSSTRADING0 @semodough. $VERA may be targeting [--] other indications in autoimmune diseases. This one is for the long haul"  
[X Link](https://x.com/FWCStocks/status/2011213007636824392)  2026-01-13T23:05Z [---] followers, [---] engagements


"$BIIB: Regarding BD management noted interest in "one more near-term growth asset something end of Phase III/early commercial" and a continued commitment to rare immunology. @JPM26:"  
[X Link](https://x.com/FWCStocks/status/2011228617699967265)  2026-01-14T00:07Z [---] followers, [---] engagements


"$CCCC: By year-end 2026: -Earn research milestones/licensing fees from collaborations with Merck KGaA Darmstadt Germany Roche and Biogen. -Deliver at least one development candidate to a collaboration partner. -Advance existing collaborations toward key milestones"  
[X Link](https://x.com/FWCStocks/status/2011421983830061200)  2026-01-14T12:55Z [---] followers, [---] engagements


"@Andre_AGTC $VERA is down about 15% in the past month. Great time to add to positions with a PDUFA by July. Most financial firms have Price Targets of $75-$100+/share. With $VERA already looking at other targets for their drug FDA approval is highly likely and it is a buyout target"  
[X Link](https://x.com/FWCStocks/status/2013657772718461005)  2026-01-20T16:59Z [---] followers, [---] engagements


"$VERA is down about 15% in the past month. Great time to add to positions with a PDUFA by July. Most financial firms have Price Targets of $75-$100+/share. With $VERA already looking at other targets for their drug FDA approval is highly likely and it is a buyout target"  
[X Link](https://x.com/FWCStocks/status/2013657840817181019)  2026-01-20T17:00Z [---] followers, [---] engagements


"$ANNX: New 52-Week High. +11% so far today on no news"  
[X Link](https://x.com/FWCStocks/status/2014078427540693430)  2026-01-21T20:51Z [---] followers, [---] engagements


"So basically $SNY blew their opportunity to acquire $VTYX. Fantastic reporting by UBS here. My repost comes in multiple comments. Proxy filing for the proposed acquisition of VTYX by LLY reveals that (1) SNY declined to exercise its ROFN on VTYX's VTX3232 and"  
[X Link](https://x.com/FWCStocks/status/2015491076480459076)  2026-01-25T18:24Z [---] followers, [---] engagements


"@PikaBulb @GeneInvesting Seems like the selloff in advance of the $GOSS February Phase [--] Readout will follow suit with a huge run. Current Price: $2.55 Price Targets Oppenheimer: $12 Cantor: Strong Buy UBS: $9 Scotia Bank: $11"  
[X Link](https://x.com/FWCStocks/status/2016185070843834437)  2026-01-27T16:22Z [---] followers, [---] engagements


"Tee Up $GOSS: Seems like the selloff in advance of the February Phase [--] Readout will follow suit with a huge run. Current Price: $2.55 Price Targets: Oppenheimer: $12 UBS: $9 Scotia Bank: $11 Cantor: Strong Buy"  
[X Link](https://x.com/FWCStocks/status/2016185502336995589)  2026-01-27T16:24Z [---] followers, [---] engagements


"@GeneInvesting @Biotech2k1 I have no skin in the game for $NTLA but interesting that Wells Fargo has a PT of $12. The share price action today on this news is not encouraging"  
[X Link](https://x.com/FWCStocks/status/2016335789446004954)  2026-01-28T02:21Z [---] followers, [---] engagements


"@semodough This is the one to watch in the VERY near term. Huge short interest high PTs from the analysts and a big catalyst coming possibly in days"  
[X Link](https://x.com/FWCStocks/status/2016348296491532506)  2026-01-28T03:11Z [---] followers, [--] engagements


"$VERA announces Chief Commercial Officer. $VERA is a strong buy at current levels ($47) with an Accelerated Approval PDUFA date of July [--]. This one will hit Cantor: $100 Evercore: $97 JPM: $95 Goldman: $95 HC Wainright: $90 https://finance.yahoo.com/news/vera-therapeutics-announces-appointment-matt-123000128.html https://finance.yahoo.com/news/vera-therapeutics-announces-appointment-matt-123000128.html"  
[X Link](https://x.com/FWCStocks/status/2016504106605511033)  2026-01-28T13:30Z [---] followers, [---] engagements


"$VERA Highlights from #JPM26. -Announced Chief Commercial Officer on 1/28/26. -Now hiring [--] sales reps. -Accelerated Approval. PDUFA date 7/7/26. -1st Dual BAFF/APRIL inhibitor. -Stopped EGFR Slope decline. -Investigating atacicept in [--] other diseases"  
[X Link](https://x.com/FWCStocks/status/2016505153961030017)  2026-01-28T13:34Z [---] followers, [---] engagements


"$GOSS: Gossamer Bio files automatic mixed securities shelf. I view this as very POSITIVE considering they have a very important Phase [--] readout days away. We usually see money being raised after a big rally on really good news. THIS IS A SIGN THE READOUT WILL BE VERY POSITIVE"  
[X Link](https://x.com/FWCStocks/status/2016620794755919947)  2026-01-28T21:13Z [---] followers, [----] engagements


"@avidresearch Pretty telling sign that a positive catalyst that will skyrocket the share price of $GOSS and cause a huge short squeezeis only days away"  
[X Link](https://x.com/FWCStocks/status/2017085972303720726)  2026-01-30T04:02Z [---] followers, [---] engagements


"Pretty telling sign that a positive catalyst that will skyrocket the share price of $GOSS and cause a huge short squeezeis only days away"  
[X Link](https://x.com/FWCStocks/status/2017086112284512693)  2026-01-30T04:02Z [---] followers, [----] engagements


"Think well see more dough @semodough This is a pretty informative clue"  
[X Link](https://x.com/FWCStocks/status/2017088490899464495)  2026-01-30T04:12Z [---] followers, [---] engagements


"@seedy19tron Just doubled my position in $GOSS. Disagree with your short position but we shall see. The research from Barclay's (1/27 with a $9 PT) HC Wainwright (1/22 with a $10 PT) and Piper Sandler (1/12 with a $15 PT) are all very supportive of a positive readout and quite compelling"  
[X Link](https://x.com/FWCStocks/status/2017319497019920613)  2026-01-30T19:30Z [---] followers, [----] engagements


"Great opportunity to grab very cheap shares of $VERA prior to approval of Atacicept for IGaN with a July [--] PDUDA. I see $VERA as a good M&A target. VERA usually trades around $48-52/share and should begin to run up soon. Numerous PTs in the $75-$100 range"  
[X Link](https://x.com/FWCStocks/status/2017865622512673049)  2026-02-01T07:40Z [---] followers, [--] engagements


"$KYTX flying under the radar and a good time to accumulate shares. Leerink Wells Fargo Morgan Stanley all with a 200-300% return forecasted from here. Cash runway into [----] is expected to fully fund SPS BLA filing 1H26 with commercial launch and a Phase [--] gMG trial"  
[X Link](https://x.com/FWCStocks/status/2017869553800294809)  2026-02-01T07:56Z [---] followers, [---] engagements


"$TECX: Up 15% so far today. Sleeping giant - A lot of big things in the pipeline. Price Targets: $60: Truist $80: Oppenheimer $101: Well Fargo $76: Raymond James $88: LifeSci Capital $85: Mizuho"  
[X Link](https://x.com/FWCStocks/status/2018347456954552552)  2026-02-02T15:35Z [---] followers, [---] engagements


"@semodough Thank you. Huge for $TECX No one knows about this March [----] article yet. Proves $LLY's trial failure was a one-off & validates $TECX. Wells Fargo: Shares go 25%+ on a positive AZN readout & 5-10x on a positive Phase [--] TX45 readout. Hold on tight https://www.cell.com/molecular-therapy-family/advances/fulltext/S3117-387X(26)00009-1 https://www.cell.com/molecular-therapy-family/advances/fulltext/S3117-387X(26)00009-1"  
[X Link](https://x.com/FWCStocks/status/2018359249588322338)  2026-02-02T16:21Z [---] followers, [---] engagements


"Huge for $TECX No one knows about this March [----] article yet. Proves $LLY's trial failure was a one-off & validates $TECX. Wells Fargo: Shares go 25%+ on a positive AZN readout & 5-10x on a positive Phase [--] TX45 readout. Hold on tight https://www.cell.com/molecular-therapy-family/advances/fulltext/S3117-387X(26)00009-1 https://www.cell.com/molecular-therapy-family/advances/fulltext/S3117-387X(26)00009-1"  
[X Link](https://x.com/anyuser/status/2018359446393569719)  2026-02-02T16:22Z [---] followers, 12.8K engagements


"@avidresearch Good point and agree. I'm only pointing out what Wells Fargo said. I think it would fly 50-100% higher from current levels"  
[X Link](https://x.com/FWCStocks/status/2018421743862382878)  2026-02-02T20:30Z [---] followers, [---] engagements


"$TECX: No one is selling. Wells Fargo expected a 25%+ run in share price AFTER positive AZN3427 news. It hasn't even been released yet and we're up almost 30% in [--] days. Wells previously noted in their research that there's a very large short interest in $TECX. Get ready"  
[X Link](https://x.com/anyuser/status/2018708346946146546)  2026-02-03T15:29Z [---] followers, [---] engagements


"$WVE: Listening to the Cantor Fitzgerald webinar with $WVE management. WV-007 data coming up is very impressive and they're excited. Confirmed it will be in Q1 [----]. -Great differentiated data. -Accelerating higher BMI fully enrolled study w/ [---] patients"  
[X Link](https://x.com/anyuser/status/2019117671636484348)  2026-02-04T18:35Z [---] followers, [---] engagements


"$WVE: Part [--] Cantor webinar. -WVE-007: Exploring strategic collaborations. -WVE-006: CEO confirmed $GSK did NOT see new data before giving full rights to $WVE. GSK continues to support $WVE. -INHBE may be studied in other therapeutic treatments like MASH"  
[X Link](https://x.com/anyuser/status/2019124563691573427)  2026-02-04T19:03Z [---] followers, [---] engagements


"$GOSS Part [--]. H.C. Wainwright (Buy $10 PT) Barclays (Overweight $9) Cantor Fitzgerald (Overweight) Piper Sandler (Buy $15) Oppenheimer ($12) PROSERA data (Feb 2026) could drive 3-5x upside if positive; M&A speculation high given management track record and PAH market ($6B+)"  
[X Link](https://x.com/anyuser/status/2020246806404427848)  2026-02-07T21:22Z [---] followers, [---] engagements


"$GOSS Institutions/Hedge funds: Octagon Capital: 7.4% (16.7M shares). New Enterprise: 7.8% (17.6M shares). BlackRock: 6.0% (13.5M shares). Perceptive Advisors: 3.8M shares (2%). Rock Springs Capital: 3.3M shares (1.7%). Total funds/institutions: [---] (up 14% QoQ)"  
[X Link](https://x.com/anyuser/status/2020247782217683389)  2026-02-07T21:26Z [---] followers, [---] engagements


"$GOSS: Seralutinib demonstrates in vitro reduction of vascular inflammatory drivers underlying pulmonary hypertension. Zhaoqing Ding Elisa Schiavi Silvia Cantoni European Respiratory Journal [----] 66(suppl 69): PA1039"  
[X Link](https://x.com/anyuser/status/2020254305434108145)  2026-02-07T21:52Z [---] followers, [----] engagements


"$AZN financials and pipeline update on February [--]. $TECX: No one is selling. Wells Fargo expected a 25%+ run in share price AFTER positive AZN3427 news. It hasn't even been released yet and we're up almost 30% in [--] days. Wells previously noted in their research that there's a very large short interest in $TECX. Get ready $TECX: No one is selling. Wells Fargo expected a 25%+ run in share price AFTER positive AZN3427 news. It hasn't even been released yet and we're up almost 30% in [--] days. Wells previously noted in their research that there's a very large short interest in $TECX. Get ready"  
[X Link](https://x.com/anyuser/status/2020685039072125114)  2026-02-09T02:23Z [---] followers, [---] engagements


"@A_May_MD Overall while the read-through validates concerns about relaxin-class efficacy (LLY AZD3427s inefficacy) TX45s design dosing and targeted approach offer a plausible path to success potentially viewing the market dip as an overreaction similar to post-Lilly events"  
[X Link](https://x.com/FWCStocks/status/2021189162301378742)  2026-02-10T11:47Z [---] followers, [---] engagements


"@A_May_MD I be doing some additional research to see if I will double down and purchase more shares on this selloff. But I will not be selling shares today and wouldnt be surprised at all if we see some buying on the dip"  
[X Link](https://x.com/FWCStocks/status/2021189665521332615)  2026-02-10T11:49Z [---] followers, [---] engagements


"$TECX: While the read-through validates concerns about relaxin-class efficacy (LLY AZD3427) TX45s design dosing and targeted approach offer a plausible path to success potentially viewing the market dip as an overreaction similar to post-Lilly events"  
[X Link](https://x.com/anyuser/status/2021189925106811032)  2026-02-10T11:50Z [---] followers, [---] engagements


"@monaco_biotech Not selling May be buying more shares today"  
[X Link](https://x.com/FWCStocks/status/2021190535105466704)  2026-02-10T11:52Z [---] followers, [--] engagements


"Wells Fargo note this morning says the pullback $TECX is overdone since we dont know details and the TX-45 trial could be differentiated. AZN news still a concern. Wells Fargo views the magnitude of the pullback as if the TX-45 trial itself failed. Maintains a $101 Price Target"  
[X Link](https://x.com/anyuser/status/2021243624411869223)  2026-02-10T15:23Z [---] followers, [---] engagements


"$TECX. Recall IF the Phase [--] TX45 readout this year is positive Wells Fargo expects a 5-10x run in share price. This was based on research in November. With AZN competition out of the way its hard not to consider loading up shares at these levels for an insane 10x+ return"  
[X Link](https://x.com/anyuser/status/2021251550606135788)  2026-02-10T15:54Z [---] followers, [---] engagements


"Even the CFO of $TECX took advantage of the panic selloff. Big things coming for $TECX soon for [--] different indications. If Prosera trial readout is positive Wells Fargo expects a 6-10x rise in share price (Price Target $101). $TECX CFO acquires $120k at open market $XBI $IBB Catalyst/readout [----] Phase [--] RXFP1 Agonist (TX45 Fc-relaxin) Heart Failure with Preserved Ejection Fraction (HFpEF) Phase [--] Group [--] Pulmonary Hypertension https://t.co/L4MXW6iXPs $TECX CFO acquires $120k at open market $XBI $IBB Catalyst/readout [----] Phase [--] RXFP1 Agonist (TX45 Fc-relaxin) Heart Failure with Preserved"  
[X Link](https://x.com/anyuser/status/2021862798867767765)  2026-02-12T08:23Z [---] followers, [---] engagements


"$VERA's upcoming FDA Approval/commercial launch will lead to much higher sales than the street is expecting. Otsuka revenue forecast this AM is 2x expectations. $VERA is an APRIL/BAFF inhibitor with superior EGFR data (Otsuka targets only BAFF). $VERA is a STRONG BUY. PT $70-$100"  
[X Link](https://x.com/anyuser/status/2022300763922260027)  2026-02-13T13:24Z [---] followers, [---] engagements


"Supplies for #HURRICANE victims stolen from church #FWCWeather http://gpwx.news/wxh6e http://gpwx.news/wxh6e"  
[X Link](https://x.com/FWCStocks/status/907374549255249922)  2017-09-11T22:45Z [---] followers, [--] engagements


"Texas company builds new oyster reef after #HURRICANE Harvey devastated population #FWCWeather http://gpwx.news/beqc1 http://gpwx.news/beqc1"  
[X Link](https://x.com/FWCWeather/status/1018993755498647557)  2018-07-16T23:00Z [---] followers, [--] engagements


"Magnitude [---] #EARTHQUAKE strikes Indonesia prompting #TSUNAMI warning #FWCWeather http://gpwx.news/6529g http://gpwx.news/6529g"  
[X Link](https://x.com/FWCWeather/status/1026094327502651392)  2018-08-05T13:15Z [---] followers, [--] engagements


"More People See Climate Change In Record Floods And Extreme #WEATHER. Will That Mean More Action #FWCWeather http://gpwx.news/8317k http://gpwx.news/8317k"  
[X Link](https://x.com/FWCWeather/status/1137303212569092096)  2019-06-08T10:19Z [---] followers, [--] engagements


"Keeping it real with a tough forecast NWS Nashville [---] PM CDT Jul [--] [----] I dont usually do this but Ive sat here for [--] minutes trying to decide what to type. My struggles revolve around the lack of any consistency between models when it comes to storm development 1/2"  
[X Link](https://x.com/FWCWeather/status/1681217980187783169)  2023-07-18T08:29Z [---] followers, [---] engagements


"Daily dose of weather humor: Tornado report near the Charleston SC area. According to the NWS video was used to confirm that the car was hi"  
[X Link](https://x.com/FWCWeather/status/1697127749305946475)  2023-08-31T06:02Z [---] followers, [---] engagements


"@hurricanetrack The Euro did terribly early on with Idalia. I see a slightly stronger ridge and slightly weaker Great Lakes trough in some of the latest models. Will be interesting to see if that trend (and a further west track) occurs. NOAA Recon and additional soundings start tomorrow"  
[X Link](https://x.com/FWCWeather/status/1699588813821968811)  2023-09-07T01:02Z [---] followers, [---] engagements


"Happy 1st Day of School This cloud-to-ground (CG) lightning bolt struck this tree (I took pictures of both) that landed on Guilderland High School in New York causing minor damage. A microburst with 50-60 mph winds and nickel sized hail also occurred"  
[X Link](https://x.com/FWCWeather/status/1699917500023001303)  2023-09-07T22:48Z [---] followers, [---] engagements


"Amazing photograph of the northern lights at the National Weather Service in Riverton Wyoming this morning. Its going to be an exciting [--] hours in the northern US and Canada for aurora borealis. Photo: NWS Riverton"  
[X Link](https://x.com/FWCWeather/status/1721147205807956236)  2023-11-05T12:47Z [---] followers, [---] engagements


"@Giants New York Giants New Years resolution: Learn how to tackle. Pathetic"  
[X Link](https://x.com/FWCWeather/status/1739439927828332904)  2023-12-26T00:16Z [---] followers, [--] engagements


"Not too often do you see a Severe Thunderstorm Warning in Puerto Rico. TJUA - Super-Res Reflectivity [--] 6:39 PM Super-Res Velocity [--] 6:34 PM #prwx"  
[X Link](https://x.com/FWCWeather/status/1786164137959047371)  2024-05-02T22:41Z [---] followers, [--] engagements


"Looks like an enormous tornado over Robert Lee (apparently a town in Texas). Just the good ole boys never meaning no harm.beats all the standing corn and causes trouble with the law since the minute it formed. KSJT - Super-Res Reflectivity [--] 5:37 PM Super-Res Velocity 1"  
[X Link](https://x.com/FWCWeather/status/1786510980932915359)  2024-05-03T21:39Z [---] followers, [---] engagements


"Heavy damage from Hurricane Beryl on the beautiful Caribbean island of Martinique. https://youtu.be/UHEK-4FWXzssi=_ZPdi5hjGZPCaSp2 https://youtu.be/UHEK-4FWXzssi=_ZPdi5hjGZPCaSp2"  
[X Link](https://x.com/FWCWeather/status/1808318408892535050)  2024-07-03T01:54Z [---] followers, [---] engagements


"@RLazear @btangyWx Funny. I was a couple of towns over in Waterville and took these. Im going to be processing a time lapse I took of the supercell with my GoPro"  
[X Link](https://x.com/FWCWeather/status/1811228324347211962)  2024-07-11T02:37Z [---] followers, [---] engagements


"G75 MPH on the OHare ASOS. WOW. Going to be a lot of flight delays and cancellations overnight KORD 160251Z 32024G50KT [--] 1/2SM R10L/3500VP6000FT +TSRA BR SQ BKN019CB BKN040 OVC140 22/21 A2972 RMK AO2 PK WND 26065/0239 RAB38 TSB26 PRESRR SLP060 CONS LTGCGIC OHD"  
[X Link](https://x.com/FWCWeather/status/1813046867954917442)  2024-07-16T03:03Z [---] followers, [---] engagements


"This week we had the opportunity of a lifetime to take a private tour of The White House. We arrived for our tour a few hours after President Biden arrived at the White House and the same day that Prime Minister Netanyahu arrived in Washington. What an experience"  
[X Link](https://x.com/FWCWeather/status/1817205752097898761)  2024-07-27T14:29Z [---] followers, [--] engagements


"Secret Service cleared the rest of our photos. Heres one from the Rose Garden at The White House. Biden was in his residence behind that far door. What an epic visit"  
[X Link](https://x.com/FWCWeather/status/1820656701424464165)  2024-08-06T03:02Z [---] followers, [--] engagements


"@POTUS Waityoure actually not on vacation and AT The White House"  
[X Link](https://x.com/FWCWeather/status/1833707627307475355)  2024-09-11T03:22Z [---] followers, [--] engagements


"Hey @MTV : Completely tasteless that MTV has their VMAs tonight and so many celebs celebrate. Red carpet After parties Who the F cares what youre wearing. On 9/11 Disgraceful"  
[X Link](https://x.com/FWCWeather/status/1834037823680221610)  2024-09-12T01:14Z [---] followers, [---] engagements


"BREAKING NEWS: Magnitude [---] earthquake just hit the Cayman Islands. Tsunami warning going up for most of the Caribbean Islands. Not sure about FL or the gulf coast yet. https://earthquake.usgs.gov/earthquakes/eventpage/us7000pcdl/executiveutm_medium=email&utm_source=ENS&utm_campaign=realtime https://earthquake.usgs.gov/earthquakes/eventpage/us7000pcdl/executiveutm_medium=email&utm_source=ENS&utm_campaign=realtime"  
[X Link](https://x.com/FWCWeather/status/1888375950565355918)  2025-02-08T23:54Z [---] followers, [---] engagements


"@GenFlynn Take a deep breath General. Not everything needs to be a conspiracy theory or extravagant unsupported assumptions. Its hot and very humid in Texas. When rare conditions like this align just right which was the case here you get terrible flash flooding. So sad"  
[X Link](https://x.com/FWCWeather/status/1941904573066514553)  2025-07-06T16:58Z [---] followers, [---] engagements


"#HURRICANE Ophelia now a major storm barreling toward Ireland #FWCWeather http://gpwx.news/5138k http://gpwx.news/5138k"  
[X Link](https://x.com/FWCWeather/status/919238842254876673)  2017-10-14T16:29Z [---] followers, [--] engagements


"$TECX: Management buy $175000 of stock on the open market"  
[X Link](https://x.com/FWCStocks/status/2022959617647714489)  2026-02-15T09:02Z [---] followers, [--] engagements


"RT @semodough: $GOSS @avidresearch am I reading that right BLACKROCK added [--] million as yesterday bringing there total to [--] million $GOS"  
[X Link](https://x.com/anyuser/status/2022331646335463634)  2026-02-13T15:26Z [---] followers, [--] engagements


"$GOSS @avidresearch am I reading that right BLACKROCK added [--] million as yesterday bringing there total to [--] million $GOSS shares $GOSS interesting take "distribution-of-outcomes event rather than a binary one" $GOSS interesting take "distribution-of-outcomes event rather than a binary one""  
[X Link](https://x.com/semodough/status/2022309750105383058)  2026-02-13T13:59Z 42.5K followers, 12.3K engagements


"$GOSS interesting take "distribution-of-outcomes event rather than a binary one" $GOSS HCW deep dive out Key Takeaways PROSERA is not a binary eventinterpretability will drive the rerate. Effect size placebo behavior and coherence across endpoints will matter as much as statistical significance. The most important risk is placebo variability not $GOSS HCW deep dive out Key Takeaways PROSERA is not a binary eventinterpretability will drive the rerate. Effect size placebo behavior and coherence across endpoints will matter as much as statistical significance. The most important risk is placebo"  
[X Link](https://x.com/anyuser/status/2021212778501963893)  2026-02-10T13:20Z 12K followers, 15K engagements


"$VERA's upcoming FDA Approval/commercial launch will lead to much higher sales than the street is expecting. Otsuka revenue forecast this AM is 2x expectations. $VERA is an APRIL/BAFF inhibitor with superior EGFR data (Otsuka targets only BAFF). $VERA is a STRONG BUY. PT $70-$100"  
[X Link](https://x.com/anyuser/status/2022300763922260027)  2026-02-13T13:24Z [---] followers, [---] engagements


"$LEGN quietly making a big push into in vivo Car-T: LVIVO-TaVec100 (CD19 x CD20) LVIVO-TaVec200 (GPRC5D) LVIVO-TaVec400 (target undisclosed) .all recently entered human trials"  
[X Link](https://x.com/anyuser/status/2022045138567274652)  2026-02-12T20:28Z 31.8K followers, [----] engagements


"New in vivo Car-T player NCI licensing patent for an anti-CD19 in vivo Car-T for autoimmune disease to $KYTX - https://public-inspection.federalregister.gov/2026-02907.pdf https://public-inspection.federalregister.gov/2026-02907.pdf"  
[X Link](https://x.com/anyuser/status/2021946516349333716)  2026-02-12T13:56Z 31.8K followers, [----] engagements


"Even the CFO of $TECX took advantage of the panic selloff. Big things coming for $TECX soon for [--] different indications. If Prosera trial readout is positive Wells Fargo expects a 6-10x rise in share price (Price Target $101). $TECX CFO acquires $120k at open market $XBI $IBB Catalyst/readout [----] Phase [--] RXFP1 Agonist (TX45 Fc-relaxin) Heart Failure with Preserved Ejection Fraction (HFpEF) Phase [--] Group [--] Pulmonary Hypertension https://t.co/L4MXW6iXPs $TECX CFO acquires $120k at open market $XBI $IBB Catalyst/readout [----] Phase [--] RXFP1 Agonist (TX45 Fc-relaxin) Heart Failure with Preserved"  
[X Link](https://x.com/anyuser/status/2021862798867767765)  2026-02-12T08:23Z [---] followers, [---] engagements


"$TECX CFO acquires $120k at open market $XBI $IBB Catalyst/readout [----] Phase [--] RXFP1 Agonist (TX45 Fc-relaxin) Heart Failure with Preserved Ejection Fraction (HFpEF) Phase [--] Group [--] Pulmonary Hypertension"  
[X Link](https://x.com/anyuser/status/2021723840116572463)  2026-02-11T23:11Z [----] followers, 14.1K engagements


"$TECX. Recall IF the Phase [--] TX45 readout this year is positive Wells Fargo expects a 5-10x run in share price. This was based on research in November. With AZN competition out of the way its hard not to consider loading up shares at these levels for an insane 10x+ return"  
[X Link](https://x.com/anyuser/status/2021251550606135788)  2026-02-10T15:54Z [---] followers, [---] engagements


"Wells Fargo note this morning says the pullback $TECX is overdone since we dont know details and the TX-45 trial could be differentiated. AZN news still a concern. Wells Fargo views the magnitude of the pullback as if the TX-45 trial itself failed. Maintains a $101 Price Target"  
[X Link](https://x.com/anyuser/status/2021243624411869223)  2026-02-10T15:23Z [---] followers, [---] engagements


"$TECX: While the read-through validates concerns about relaxin-class efficacy (LLY AZD3427) TX45s design dosing and targeted approach offer a plausible path to success potentially viewing the market dip as an overreaction similar to post-Lilly events"  
[X Link](https://x.com/anyuser/status/2021189925106811032)  2026-02-10T11:50Z [---] followers, [---] engagements


"$AZN financials and pipeline update on February [--]. $TECX: No one is selling. Wells Fargo expected a 25%+ run in share price AFTER positive AZN3427 news. It hasn't even been released yet and we're up almost 30% in [--] days. Wells previously noted in their research that there's a very large short interest in $TECX. Get ready $TECX: No one is selling. Wells Fargo expected a 25%+ run in share price AFTER positive AZN3427 news. It hasn't even been released yet and we're up almost 30% in [--] days. Wells previously noted in their research that there's a very large short interest in $TECX. Get ready"  
[X Link](https://x.com/anyuser/status/2020685039072125114)  2026-02-09T02:23Z [---] followers, [---] engagements


"$TECX: No one is selling. Wells Fargo expected a 25%+ run in share price AFTER positive AZN3427 news. It hasn't even been released yet and we're up almost 30% in [--] days. Wells previously noted in their research that there's a very large short interest in $TECX. Get ready"  
[X Link](https://x.com/anyuser/status/2018708346946146546)  2026-02-03T15:29Z [---] followers, [---] engagements


"$LEGN ($17/sh): Partnership with JNJ. Consistent durable efficacy and particularly compelling outcomes for Carvykti when used in patients' multiple myeloma treatment journey. PTs: Barclays ($80) HCW ($50) Cowan ($26) Oppenheimer ($75) MS:($50). s https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-present-carvyktir-data-2026-tandem-meetings https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-present-carvyktir-data-2026-tandem-meetings"  
[X Link](https://x.com/anyuser/status/2020683857146544563)  2026-02-09T02:19Z [---] followers, [---] engagements


"$GOSS: Seralutinib demonstrates in vitro reduction of vascular inflammatory drivers underlying pulmonary hypertension. Zhaoqing Ding Elisa Schiavi Silvia Cantoni European Respiratory Journal [----] 66(suppl 69): PA1039"  
[X Link](https://x.com/anyuser/status/2020254305434108145)  2026-02-07T21:52Z [---] followers, [----] engagements


"$GOSS Institutions/Hedge funds: Octagon Capital: 7.4% (16.7M shares). New Enterprise: 7.8% (17.6M shares). BlackRock: 6.0% (13.5M shares). Perceptive Advisors: 3.8M shares (2%). Rock Springs Capital: 3.3M shares (1.7%). Total funds/institutions: [---] (up 14% QoQ)"  
[X Link](https://x.com/anyuser/status/2020247782217683389)  2026-02-07T21:26Z [---] followers, [---] engagements


"$GOSS Part [--]. H.C. Wainwright (Buy $10 PT) Barclays (Overweight $9) Cantor Fitzgerald (Overweight) Piper Sandler (Buy $15) Oppenheimer ($12) PROSERA data (Feb 2026) could drive 3-5x upside if positive; M&A speculation high given management track record and PAH market ($6B+)"  
[X Link](https://x.com/anyuser/status/2020246806404427848)  2026-02-07T21:22Z [---] followers, [---] engagements


"Theres a lot of short-selling occurring with $GOSS prior to an enormous binary event/readout in the next couple of weeks. I suspect well see a wave of buying begin soon. Many positive research reports support a positive readout with much higher results any Price Targets"  
[X Link](https://x.com/anyuser/status/2019993941383250228)  2026-02-07T04:37Z [---] followers, [----] engagements


"$WVE: Part [--] Cantor webinar. -WVE-007: Exploring strategic collaborations. -WVE-006: CEO confirmed $GSK did NOT see new data before giving full rights to $WVE. GSK continues to support $WVE. -INHBE may be studied in other therapeutic treatments like MASH"  
[X Link](https://x.com/anyuser/status/2019124563691573427)  2026-02-04T19:03Z [---] followers, [---] engagements


"$WVE: Listening to the Cantor Fitzgerald webinar with $WVE management. WV-007 data coming up is very impressive and they're excited. Confirmed it will be in Q1 [----]. -Great differentiated data. -Accelerating higher BMI fully enrolled study w/ [---] patients"  
[X Link](https://x.com/anyuser/status/2019117671636484348)  2026-02-04T18:35Z [---] followers, [---] engagements


"Huge for $TECX No one knows about this March [----] article yet. Proves $LLY's trial failure was a one-off & validates $TECX. Wells Fargo: Shares go 25%+ on a positive AZN readout & 5-10x on a positive Phase [--] TX45 readout. Hold on tight https://www.cell.com/molecular-therapy-family/advances/fulltext/S3117-387X(26)00009-1 https://www.cell.com/molecular-therapy-family/advances/fulltext/S3117-387X(26)00009-1"  
[X Link](https://x.com/anyuser/status/2018359446393569719)  2026-02-02T16:22Z [---] followers, 12.8K engagements


"Research paper: "These findings support AZD5462 as a promising novel therapy for chronic heart failure. A phase [--] study of AZD5462 is currently underway in patients with chronic heart failure.""  
[X Link](https://x.com/anyuser/status/2018359666376388626)  2026-02-02T16:23Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

@FWCStocks Avatar @FWCStocks FWCStocks

FWCStocks posts on X about $tecx, $vera, $goss, $vtyx the most. They currently have [------] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.

Engagements: [-----] #

Engagements Line Chart

  • [--] Week [-----] -63%
  • [--] Month [------] +104%
  • [--] Months [------] +15,098%
  • [--] Year [------] -36%

Mentions: [--] #

Mentions Line Chart

  • [--] Month [--] -51%
  • [--] Months [---] +6,233%
  • [--] Year [---] +1,492%

Followers: [------] #

Followers Line Chart

  • [--] Week [---] +0.67%
  • [--] Month [---] +5.60%
  • [--] Months [---] +18%
  • [--] Year [---] +18%

CreatorRank: [---------] #

CreatorRank Line Chart

Social Influence

Social category influence stocks finance countries currencies technology brands financial services cryptocurrencies travel destinations social networks celebrities

Social topic influence $tecx, $vera, $goss, $vtyx, target, $wve, $annx, $cccc, in the, acquisition

Top accounts mentioned or mentioned by @amaymd @seedy19tron @biotechiq @pharmdca @jfais20 @adamfeuerstein @pawcio2009 @bioinvestor24 @biotechnerd1 @rnaianalyst @doepkemichel @bosstrading0 @biotech2k1 @avidresearch @tradeacct17 @biostocks @andreagtc @stocksavvyshay @geneinvesting @themarketraven

Top assets mentioned Vera Therapeutics, Inc. (VERA) Ventyx Biosciences, Inc. (VTYX) Wave Life Sciences Ltd. Ordinary Shares (WVE) Annexon, Inc. (ANNX) C4 Therapeutics, Inc (CCCC) Eli Lilly and Company (LLY) Climb Bio, Inc (CLYM) Kyverna Therapeutics, Inc. (KYTX) Synthetify (SNY) Sanofi (SNY) BlackRock Inc (BLK) Legend Biotech Corp (LEGN) Viking Holdings Ltd (VIK) AstraZeneca PLC (AZN) GSK plc (GSK) Xilio Therapeutics, Inc. (XLO) Adagene Inc. (ADAG) The 99% Community (99) Uber Technologies, Inc. (UBER) SuperRare (RARE)

Top Social Posts

Top posts by engagements in the last [--] hours

"2026: I'm ONLY focusing on clinical stage biotechs that have catalysts in [----]. I think these companies will move the needle nicely. 85% return overall since June '25. My current slate: $ANNX $CCCC $CLYM $GOSS $KYTX $PALI $STRO $TECX $VERA. Sold $VTYX"
X Link 2026-01-14T01:45Z [---] followers, [---] engagements

"@jfais20 11/19: Wells Fargo raised the PT on $ANNX to $27 keeps it Overweight raises its POS to 55% that Phase [--] trial in GA will be positive in 2H26. Wells believes the it offers a significant asymmetric risk/reward skew with the potential for VC-like upside in the next [--] months"
X Link 2026-01-05T23:34Z [---] followers, [--] engagements

"$ANNX is Wells Fargo's #2 TOP PICK in SMID Cap Biotech behind $ARGX. Wells Fargo: We believe the [----] setup offers a significant asymmetric risk/reward with Venture Capital-like returns of more than 10x in the NTM. We expect shares to run up ahead of 2H data"
X Link 2026-01-09T04:45Z [---] followers, [---] engagements

"$ANNX 52-Week High. Wells Fargo #2 TOP PICK. We believe [----] offers a significant risk/reward with Venture Capital-like returns of more than 10x. Expect shares to run up ahead of 2H data. They present tomorrow at #JPM. Have you looked at this @Pharmdca @jfais20 @TheMarketRaven"
X Link 2026-01-13T15:42Z [---] followers, [---] engagements

"@jfais20 I'm focusing on clinical/pre-clinical stage biotechs that have catalysts this year or next. These companies will move the needle one way or the other. Up 75% overall since June '25. $ANNX $CCCC $CLYM $GOSS $KYTX $PALI $STRO $TECX $VERA. That's all of them for right now"
X Link 2026-01-14T01:38Z [---] followers, [---] engagements

"@jfais20 $ANNX 52-Week High today. Wells Fargo #2 TOP BIOTECH PICK. "We believe [----] offers a significant risk/reward with Venture Capital-like returns of more than 10x. Expect shares to run up ahead of 2H data". They present tomorrow at #JPM"
X Link 2026-01-14T03:13Z [---] followers, [--] engagements

"$LEGN ($17/sh): Partnership with JNJ. Consistent durable efficacy and particularly compelling outcomes for Carvykti when used in patients' multiple myeloma treatment journey. PTs: Barclays ($80) HCW ($50) Cowan ($26) Oppenheimer ($75) MS:($50). s https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-present-carvyktir-data-2026-tandem-meetings https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-present-carvyktir-data-2026-tandem-meetings"
X Link 2026-02-09T02:19Z [---] followers, [---] engagements

"$TECX: Management buy $175000 of stock on the open market"
X Link 2026-02-15T09:02Z [---] followers, [--] engagements

"#HURRICANE Florence weakens to Cat [--] storm but storm surge expected to hit catastrophic levels #FWCWeather http://gpwx.news/sf18j http://gpwx.news/sf18j"
X Link 2018-09-13T03:46Z [---] followers, [--] engagements

"Thousands are evacuated as monster #HURRICANE Willa descends on Mexico #FWCWeather http://gpwx.news/rx2bm http://gpwx.news/rx2bm"
X Link 2018-10-23T10:31Z [---] followers, [--] engagements

"Iran puts death toll from #FLOODING at [--] #FWCWeather http://gpwx.news/5473k http://gpwx.news/5473k"
X Link 2019-04-03T15:02Z [---] followers, [--] engagements

"@StockSavvyShay I think you should look into $ADAG $CCCC $TECX and $VTYX. You're welcome"
X Link 2025-10-06T22:30Z [---] followers, [----] engagements

"@Pharmdca Hard pass"
X Link 2025-10-15T19:44Z [---] followers, [--] engagements

"Flights wont be leaving from Montego Bay for quite some time. OMG. Sangster International Airport Mashup in Montego mash up Posted by https://t.co/g1OkuSko5T https://t.co/LS446qaduz OMG. Sangster International Airport Mashup in Montego mash up Posted by https://t.co/g1OkuSko5T https://t.co/LS446qaduz"
X Link 2025-10-29T06:08Z [---] followers, [---] engagements

"@pawcio2009 @seedy19tron @A_May_MD @trade_acct_17 $VTYX: Catalyst [--] - VTX3232 results were positive and had surprisingly good results. Sanofi has right to first refusal to partner with VTYX and should happen anytime. Catalyst 2: A huge Ph2 readout (4Q25) for VTX2735 for Recurrent Pericarditis should rocket VTYX much higher"
X Link 2025-11-02T11:55Z [---] followers, [---] engagements

"@pawcio2009 @seedy19tron @A_May_MD @trade_acct_17 $VERA: Financials this week. This one is going to see an enormous run on its Ph2 readout. VERA is disease-modifying. Theyll be filing a BLA with accelerated approval soon"
X Link 2025-11-02T12:05Z [---] followers, [---] engagements

"@cigs1234 Pretty sure you should look at $WVE a slew of surprising findings and how their drug helps patients with liver damage. I think it was so surprising that they created a new drug trial for it WAVE-008 (among numerous other collabs and studies they have going on)"
X Link 2025-11-02T13:22Z [---] followers, [---] engagements

"@Pharmdca MSNBC article today: The China acquisition and other smaller players raised questions about the fate of U.S. obesity biotechs like Viking Therapeutics which were once hot takeover targets. Some argue their drugs havent differentiated themselves enough from existing treatments"
X Link 2025-11-02T21:07Z [---] followers, [---] engagements

"@bioinvestor24 MSNBC article today: The China acquisition and other smaller players raised questions about the fate of U.S. obesity biotechs like Viking Therapeutics which were once hot takeover targets. Some argue their drugs havent differentiated themselves enough from existing treatments"
X Link 2025-11-02T21:08Z [---] followers, [--] engagements

"@bioinvestor24 MSNBC article today: The China acquisition and other smaller players raised questions about the fate of U.S. obesity biotechs like Viking Therapeutics which were once hot takeover targets. Some argue their drugs havent differentiated themselves enough from existing treatments"
X Link 2025-11-02T21:08Z [---] followers, [---] engagements

"@bioinvestor24 https://www.cnbc.com/2025/11/02/whats-next-for-the-weight-loss-drug-market-pills-rivals-insurance.html https://www.cnbc.com/2025/11/02/whats-next-for-the-weight-loss-drug-market-pills-rivals-insurance.html"
X Link 2025-11-02T21:10Z [---] followers, [--] engagements

"@bioinvestor24 https://www.cnbc.com/2025/11/02/whats-next-for-the-weight-loss-drug-market-pills-rivals-insurance.html https://www.cnbc.com/2025/11/02/whats-next-for-the-weight-loss-drug-market-pills-rivals-insurance.html"
X Link 2025-11-02T21:10Z [---] followers, [--] engagements

"@Pharmdca https://www.cnbc.com/2025/11/02/whats-next-for-the-weight-loss-drug-market-pills-rivals-insurance.html https://www.cnbc.com/2025/11/02/whats-next-for-the-weight-loss-drug-market-pills-rivals-insurance.html"
X Link 2025-11-02T21:10Z [---] followers, [--] engagements

"My Sunday night excitement.watching this video. How long does it take for him to get out This was captured on I-40 in Arkansas during a snowstorm https://t.co/N10O9MON0N How long does it take for him to get out This was captured on I-40 in Arkansas during a snowstorm https://t.co/N10O9MON0N"
X Link 2025-11-10T08:43Z [---] followers, [--] engagements

"I always thought about the extremely rare chance that a plane could collide with a weather balloon but never actually heard of it happening before. https://nypost.com/2025/11/22/us-news/weather-balloon-shattered-windshield-of-united-airlines-flight-36000-feet-over-utah-ntsb/utm_social_handle_id=134486075205&utm_medium=social&sr_share=facebook&utm_campaign=nypost&utm_source=facebook&utm_social_post_id=590403776&utm_medium=social&utm_campaign=nypost&utm_source=facebook&sr_share=fa"
X Link 2025-11-23T21:19Z [---] followers, [--] engagements

"@Biotechnerd1 $VERA: I added on the stupid panic selloff after hours last night"
X Link 2025-11-26T16:35Z [---] followers, [--] engagements

"Amazing opportunity to buy $VERA. Otuska received the 1st FDA Approval for IGAN yesterday. $VERA has even better EGFR numbers and similar reduction in protein in urine. CANTOR: Reiterates $100 PT HC Wainwright: $90 PT Wells Fargo: $70 PT @seedy19tron @BioStocks @Pharmdca"
X Link 2025-11-26T16:48Z [---] followers, [---] engagements

"@A_May_MD: Wells Fargo Note this evening: In our follow-up with mgmt they highlighted this was more logistics than anything and permits the ability to introduce QD dose ranging into pts sooner ahead of a planned Ph3 in 2H26 vs. looking at QD later. More"
X Link 2025-12-03T02:43Z [---] followers, [--] engagements

"$VTYX: Wells Fargo note this evening: In our follow-up with mgmt they highlighted this was more logistics than anything and permits the ability to introduce QD dose ranging into pts sooner ahead of a planned Ph3 in 2H26 vs. looking at QD later. More @A_May_MD"
X Link 2025-12-03T02:45Z [---] followers, [---] engagements

"@MartinShkreli You might get sued for slander or libel"
X Link 2025-12-03T17:09Z [---] followers, [---] engagements

"BREAKING (part 1): $VERA's going to be a blockbuster From today's CITI Healthcare Conference: -KDIGO's next release of kidney disease guidelines is planned around expected approval of Atacicept in July '26. @_Biotech_iQ @A_May_MD @adamfeuerstein @seedy19tron @Biotechnerd1"
X Link 2025-12-03T21:36Z [---] followers, [---] engagements

"BREAKING (part 2): $VERA From today's CITI Healthcare Conference: --VERA identified [--] additional autoimmune indications outside of kidney disease that Atacicept would have successful clinical outcomes. @_Biotech_iQ @A_May_MD @adamfeuerstein @seedy19tron @Biotechnerd1"
X Link 2025-12-03T21:38Z [---] followers, [---] engagements

"$VERA: JP Morgan: Price Target raised to $99 from $52. 7:00 PM 12/3/25. Updated model following multiple competitive updates for sibeprenlimab. With market dynamics & TAM JPM sees the product as strategically attractive. @_Biotech_iQ @A_May_MD @adamfeuerstein @seedy19tron"
X Link 2025-12-04T00:17Z [---] followers, [---] engagements

"@BillAckman @Uber @dkhos Blast them with emails Executive Emails Dara Khosrowshahi (CEO): khosrowshahid@uber.com Troy Stevenson (Global Head of Customer Operations): stevensont@uber.com (or TroyS@uber.com on LinkedIn) Tomasz Krawczyk (Senior Director Community Operations): krawczykt@uber.com"
X Link 2025-12-06T15:43Z [---] followers, [---] engagements

"@_Biotech_iQ VTYX looks quite superior from this data. I am long $VTYX because they also have several significant readouts coming (VTX 2735).not to mention a decision by Sanofi to partner on VTYX [----] by January [----] (estimate per Wells Fargo)"
X Link 2025-12-07T22:25Z [---] followers, [---] engagements

"@Andre_AGTC VTYX is awaiting a decision on Sanofi which has the right of first refusal to partner the drug.or maybe outright acquire them. A decision by Sanofi is expected in the next [--] days or so per Wells Fargo. Conference calls suggest they have other partners waiting in the wings"
X Link 2025-12-07T23:05Z [---] followers, [---] engagements

"@Andre_AGTC @grok VTYX is likely to get a partnership or acquisition by Sanofi or another large pharma company by the end of January (or sooner). Sanofi has the right of first refusal. Share price is going to start jumping on anticipation now"
X Link 2025-12-08T19:13Z [---] followers, [--] engagements

"$SNTI: 12/9/25-Leerink Partners initiated coverage with a Outperform rating & a $6.00 price target. Positive Phase [--] clinical data for SENTI-202 presented at ASH showed a 50% ORR and 42% complete remission rate in relapsed/refractory acute myeloid leukemia. @A_May_MD @semodough"
X Link 2025-12-09T16:31Z [---] followers, [---] engagements

"@RNAiAnalyst 12/12: Wedbush raises price target on Wave Life Sciences adds to Best Ideas List Wedbush analyst Yun Zhong added Outperform-rated Wave Life Sciences to the firm's Best Ideas List and raised the price target on the stock to $33 from $20"
X Link 2025-12-12T11:58Z [---] followers, [----] engagements

"@BiotechAnalysst $STRO this morning: Sutro Biopharma PT raised to $51 from $5 at Deutsche Bank and keeps a Buy rating on the shares. The company's STRO-004 is entering the Clinic while its dual payload antibody-drug conjugates will emerge in [----] the analyst tells investors in a research note"
X Link 2025-12-17T14:16Z [---] followers, [---] engagements

"@BioStocks $STRO this morning: Sutro Biopharma PT raised to $51 from $5 at Deutsche Bank and keeps a Buy rating on the shares. The company's STRO-004 is entering the Clinic while its dual payload antibody-drug conjugates will emerge in [----] the analyst tells investors"
X Link 2025-12-17T14:17Z [---] followers, [--] engagements

"$STRO: Sutro Biopharma price target raised to $51 from $5 at Deutsche Bank. Deutsche Bank keeps a Buy rating on the shares. The company's STRO-004 is entering the Clinic while its dual payload antibody-drug conjugates will emerge in [----] the analyst tells investors"
X Link 2025-12-17T15:35Z [---] followers, [--] engagements

"Also started a large position in $GOSS"
X Link 2025-12-17T22:04Z [---] followers, [---] engagements

"$TECX: Expecting a big AZN3427 readout within the next week that will have major implications on TX45 and TECX. WELLS FARGO: Stock moves 25%+ higher on a positive AZN3427 update by end of [----] with a 5-10x move in share price on positive TX45-Ph2 APEX study readout in 2026"
X Link 2025-12-19T15:27Z [---] followers, [---] engagements

"$WVE: Price target raised to $30 from $22 at H.C. Wainwright. Part [--] of [--]. The firm says its key opinion leader and dose-response modeling confirm WVE-007 as a potential "body recomposition" agent delivering 9.4% visceral fat loss and 3.2% lean mass gain with zero GI issues"
X Link 2025-12-19T15:52Z [---] followers, [---] engagements

"Part 2/3: Experts identify significant unmet need and add-on to GLP-1s solving the issues of visceral adiposity muscle loss and weight rebound. Higher doses and a clean safety profile will accelerate fat loss to competitive levels and a differentiated commercial label"
X Link 2025-12-19T15:55Z [---] followers, [--] engagements

"$VERA $VTYX $WVE and $TECX are my highest confidence stocks for [----]. $VERA will be a $95+ stock after FDA approval. ($VERA indicated on a call that their results showed stable and even improved eGFR opens the door for many new indications. Think ACQUISITION TARGET)"
X Link 2025-12-19T16:14Z [---] followers, [---] engagements

"@A_May_MD $AZN is supposed to have a readout for AZN3427 with a big readthrough for TECXs TX45 drug. Wells Fargo saying TECX could be +25% on AZNs readout and a 5-10x run for TECX if the TX45 readout is favorable next year"
X Link 2025-12-24T03:24Z [---] followers, [---] engagements

"Merry Christmas from the Turks and Caicos Islands"
X Link 2025-12-25T22:00Z [---] followers, [---] engagements

"$GSK purchases [-------] shares of $WVE on 12/15/25 at $19 per share (valued at $27.93 million)increasing GSKs total beneficial ownership to [--------] shares (about 14.8% of WVEs outstanding shares). ACQUISITION TARGET for 2026"
X Link 2025-12-28T12:10Z [---] followers, [---] engagements

"Goodbye Ilhan Omar You see that glow flashing in the corner of your eye That's your career dissipation light. It just went into high gear." @elonmusk https://nypost.com/2025/12/27/us-news/ilhan-omars-hubbys-30m-firm-quietly-scrubs-names-from-website-as-squad-member-faces-mounting-questions-on-sudden-wealth-amid-minnesota-welfare-fraud/ https://nypost.com/2025/12/27/us-news/ilhan-omars-hubbys-30m-firm-quietly-scrubs-names-from-website-as-squad-member-faces-mounting-questions-on-sudden-wealth-amid-minnesota-welfare-fraud/"
X Link 2025-12-29T03:34Z [---] followers, [--] engagements

"$RARE. JP Morgan had a terrible forecast from 10/12/25. JPMorgan analyst Anupam Rama: [--]. Placed RARE on "Positive Catalyst Watch" ahead of ORBIT & COSMIC study updates. [--]. Confidence in setrusumab's success with a PT of &125. [--]. Sees a "very positive" reward/risk profile"
X Link 2025-12-29T14:23Z [---] followers, [---] engagements

"@RNAiAnalyst Im sitting out the ABVX hype machine. Not worth it to me. If M&A doesnt happen the selloff will be significant"
X Link 2025-12-30T12:35Z [---] followers, [---] engagements

"Recall $SNY has the first right of refusal to partner with (or flat out acquire) $VTYX. Wells Fargo predicts that this should happen before the end of January based on their research of other acquisitions"
X Link 2025-12-30T16:26Z [---] followers, [---] engagements

"$CLYM FILES SEC COMPLAINT AGAINST ALUMIS $ALMS AND ACELYRIN RELATING TO A DISPUTE CONCERNING A PURCHASE AGREEMENT DATED JANUARY [--] [----]. CLYM SEEKS DECLARATORY JUDGMENT THAT CO'S BUDOPRUTUG DRUG CANDIDATE IS NOT "PRODUCT" AND IT DOES NOT OWE A MILESTONE PAYMENT SOUGHT BY $ALMS"
X Link 2025-12-31T23:50Z [---] followers, [---] engagements

"$ANNX is Wells Fargo's #2 TOP PICK in SMID Cap Biotech behind $ARGX. Wells Fargo: We believe the [----] setup offers a significant asymmetric risk/reward with Venture Capital-like returns of more than 10x in the NTM. We expect shares to run up ahead of 2H data"
X Link 2026-01-02T14:14Z [---] followers, [---] engagements

"@RNAiAnalyst Agreed. Long and strong. ARWR just made the case for $WVE"
X Link 2026-01-06T13:14Z [---] followers, [---] engagements

"$WVE was the first to the party with the results. Expecting several upgrades for $WVE based on the confirmational data from $ARWR this morning. $WVE will be a strong buyout candidate this year because of WVE-007 Aatd and possible even their HD drug"
X Link 2026-01-06T13:22Z [---] followers, [---] engagements

"Im up 150% on my $WVE investment. Everything I own is playing with the banks money right now. Yet even with $WVE up 24% pre-market on $ARWRs news I see no reason to scale back my position/take more profits given the huge potential $WVE has. Do you agree or disagree"
X Link 2026-01-06T13:32Z [---] followers, [---] engagements

"@adamfeuerstein Wells Fargo valued $VTYX at $25/share if VTX2735 and VTX3232 was partnered.let alone bought out. That's would be an additional 75% gain from current after-hours levels"
X Link 2026-01-06T21:14Z [---] followers, [----] engagements

"What stock price do you think $VTYX will settle at with an $LLY purchase $LLY in final talks to buy $VTYX Wells Fargo valued $VTYX at $25/share if VTX2735 and VTX3232 was partnered.let alone bought out. That's would be an additional 75% gain from current after-hours levels"
X Link 2026-01-06T21:20Z [---] followers, [---] engagements

"@PersimmonTI I finally got my first M&A. Bought at $4. Up 306% due to some selling high and buying low I did in the past [--] months. Still holding as I think the buyout price would make $VTYX in the $20-$25 range"
X Link 2026-01-06T22:45Z [---] followers, [---] engagements

"@_Biotech_iQ $LLY knows $VTYX is on to big things. If multiple outlets are reporting the buyout rumor like the WSJ says.then it's going to happen. To your point I also did not sell any shares after hours because I think the deal could be well over $1B (with a $VTYX value of $20-25+/share)"
X Link 2026-01-07T00:24Z [---] followers, [---] engagements

"@_Biotech_iQ 11/5/25: HC Wainwright: "Recent data from Ventyx's VTX3232 Phase [--] trial for obesity and cardiovascular risk "largely mimics" data presented from IL-6 inhibitor pacibekitug from Tourmaline which was acquired by Novartis for $1.4B in September""
X Link 2026-01-07T00:45Z [---] followers, [--] engagements

"Looks like $LLY flew to London not for a deal with $ABVX but because theyve been working on opening a new biotech development hub there. https://www.fiercebiotech.com/biotech/weight-loss-windfall-lilly-looks-become-backbone-global-innovation https://www.fiercebiotech.com/biotech/weight-loss-windfall-lilly-looks-become-backbone-global-innovation"
X Link 2026-01-07T04:17Z [---] followers, [---] engagements

"More ammo supporting the $LLY / $VTYX buyout rumor in this LinkedIn post where the $VTYX CEO congratulates $LLYs new Director of Corporate Business Development who discusses $LLYs aggressive Business Development interests"
X Link 2026-01-07T04:29Z [---] followers, [---] engagements

"$VTYX: I'm not convinced there won't be a bidding war $SNY has the Right of First Refusal yet reports say $LLY is the poss. acquirer. Doesn't make complete sense why $SNY would drop it. The $14 rumored price may be too low. Keep in mind: Wells Fargo PT is $25 and UBS PT is $20"
X Link 2026-01-07T17:46Z [---] followers, [--] engagements

"@doepke_michel $VTYX: I'm not convinced there won't be a bidding war $SNY has the Right of First Refusal yet reports say $LLY is the poss. acquirer. Doesn't make complete sense why $SNY would drop it. The $14 rumored price may be too low. Keep in mind: Wells Fargo PT is $25 and UBS PT is $20"
X Link 2026-01-07T17:47Z [---] followers, [---] engagements

"@BOSSTRADING0 @ChartsRUs0 $VTYX: I'm not convinced there won't be a bidding war $SNY has the Right of First Refusal yet reports say $LLY is the poss. acquirer. Doesn't make complete sense why $SNY would drop it. The $14 rumored price may be too low. Keep in mind: Wells Fargo PT is $25 and UBS PT is $20"
X Link 2026-01-07T17:48Z [---] followers, [---] engagements

"@RNAiAnalyst $VTYX: I'm not convinced there won't be a bidding war $SNY has the Right of First Refusal yet reports say $LLY is the poss. acquirer. Doesn't make complete sense why $SNY would drop it. The $14 rumored price may be too low. Keep in mind: Wells Fargo PT is $25 and UBS PT is $20"
X Link 2026-01-07T17:49Z [---] followers, [---] engagements

"Struggling with $ED Theres no pill to tell you when to buy or sell. 😂😂😂"
X Link 2026-01-09T01:15Z [---] followers, [--] engagements

"@Biotech2k1 Youre the only one who posts daily about how you want to sell and that theres a biotech bubble. I see this from nobody else and instead theses and risk are based on expected growth and development of their products"
X Link 2026-01-12T13:59Z [---] followers, [---] engagements

"The $VERA PDUFA will be close to the new PDUFA date for $TVTX. $VERA presents this afternoon at #JPM. $VERA has a very high likelihood of approval is a much better company to own and share price should at least double (see numerous Price Targets) leading up to/after approval"
X Link 2026-01-13T19:00Z [---] followers, [---] engagements

"-Sales reps initially targeting [----] nephrologists. -More results later this year about targeting other autoimmune diseases. -More trial data coming at ERA in June. -$779M in cash. $425M additional non-dilutive avail"
X Link 2026-01-13T22:59Z [---] followers, [--] engagements

"@BOSSTRADING0 UBS upgraded $GOSS to Buy with a price target of $9. Views the risk/reward as "compelling" into the Ph [--] pulmonary arterial hypertension data in February [----]. Probability of success is underappreciated and seralutinib offers a "differentiated" mechanism of action"
X Link 2026-01-14T03:19Z [---] followers, [---] engagements

"@doepke_michel Interesting by year-end 2026: -Earn research milestones/licensing fees from collaborations with Merck KGaA Darmstadt Germany Roche and Biogen. -Deliver at least one development candidate to a collaboration partner. -Advance existing collaborations toward key milestones"
X Link 2026-01-14T12:55Z [---] followers, [--] engagements

"$PALI: Buying the selloff. 1) Phase 1b data for PALI-2108 in fibrostenotic Crohn's disease (FSCD) expected in (Q1 2026). Topline safety pharmacokinetics (PK) and pharmacodynamics (PD) data. 2) The Crohn's & Colitis Foundation just made a $500000 investment in $PALI"
X Link 2026-01-16T16:34Z [---] followers, [----] engagements

"@diamondguyizzy There was a run-up and peak at the end of December when they were granted a patent by Japan for PALI-2108. I think this one is under the radar. Hence why I am slowly building my position"
X Link 2026-01-16T16:39Z [---] followers, [---] engagements

"$PALI today announced that two abstracts highlighting its lead program PALI-2108 have been selected for presentation at two premier international inflammatory bowel disease (IBD) meetings in early 2026"
X Link 2026-01-16T16:44Z [---] followers, [---] engagements

"@Albrtspain Piper Sandler initiated coverage of $PALI with an Overweight rating and $25 price target. Piper says Palisade "is a great name to own" ahead of PALI-2108's Phase1b fibrostenotic Crohn's disease data in Q1. The shares are undervalued considering that PDE4 inhibition is validated"
X Link 2026-01-17T04:27Z [---] followers, [---] engagements

"@pawcio2009 Next up $PALI. +12% pop today on no news"
X Link 2026-01-20T21:13Z [---] followers, [---] engagements

"Nothing says upcoming failed drug trial like a press release at [--] pm on a Friday announcing upcoming results on Monday Okay okay well see but just wondering. $SRPT"
X Link 2026-01-23T23:13Z [---] followers, [---] engagements

"(2) LLY was ultimately the only bidder on VTYX despite SNY and another large pharma company conducting advanced due diligence although negotiations with LLY coincided with holiday recesses for SNY and Party A"
X Link 2026-01-25T18:25Z [---] followers, [--] engagements

"Recall in Sep [----] SNY invested $27M into VTYX and received a right of first negotiation (ROFN) on VTYX's CNS-penetrant NLRP3 inhibitor VTX3232. The negotiation period of the ROFN was to open after VTYX shared obesity data for '3232 in Oct 2025"
X Link 2026-01-25T18:25Z [---] followers, [--] engagements

"VTYX contacted [--] biopharmaceutical companies (including LLY and SNY). Of these [--] did not express interest [--] expressed interest in a license of '3232 for neurological indications alone [--] conducted preliminary due diligence but did not pursue"
X Link 2026-01-25T18:25Z [---] followers, [--] engagements

"2 conducted initial due diligence but required additional clinical data and three (LLY SNY and another large pharma company referred to as Party A) entered advanced due diligence"
X Link 2026-01-25T18:26Z [---] followers, [--] engagements

"VTYX representatives contacted Party A on Dec [--] and SNY on Dec [--] to inform them VTYX had received an acquisition proposal. Party A stated their due diligence was ongoing and they were unlikely to accelerate any deliberations over the holidays"
X Link 2026-01-25T18:26Z [---] followers, [--] engagements

"The representative of VTYX did not respond due to the ongoing exclusivity agreement. On Jan [--] VTYX and LLY signed and announced the merger agreement"
X Link 2026-01-25T18:27Z [---] followers, [--] engagements

"President Trump calls #HURRICANE Irma some big monster #FWCWeather http://gpwx.news/0rmwv http://gpwx.news/0rmwv"
X Link 2017-09-11T00:46Z [---] followers, [--] engagements

"$XLO: You might want to look at this one -$17.5M milestone achieved with Gilead -Abbvie and Xilio Collab: Xilio receives $52.0M in upfront payments $10.0M equity investment. Eligible for $2.1B in fees milestones royalties. @StockSavvyShay https://finance.yahoo.com/news/xilio-therapeutics-announces-upcoming-presentations-130000244.html https://finance.yahoo.com/news/xilio-therapeutics-announces-upcoming-presentations-130000244.html"
X Link 2025-10-07T14:20Z [---] followers, [---] engagements

"@pawcio2009 @seedy19tron @A_May_MD @trade_acct_17 Others to watch these week: $CLYM $XLO $QURE $VTYX"
X Link 2025-11-02T12:06Z [---] followers, [---] engagements

"$VERA +13% today going +100-200% next few months. VERY confident. Jim Meyers former E.V.P of Gilead named to VERA's Board of Directors today. VERA submitted BLA with Accelerated Approval to FDA. [--] conferences next week. @seedy19tron @BioStocks @Pharmdca https://finance.yahoo.com/news/vera-therapeutics-appoints-veteran-biotech-210500545.html https://finance.yahoo.com/news/vera-therapeutics-appoints-veteran-biotech-210500545.html"
X Link 2025-11-26T23:19Z [---] followers, [--] engagements

"$VERA Presents on 12/2/25 at the Evercore Healthcare Conference. $CLYM Presents on 12/2/25 at the Piper Sandler Healthcare Conference. $CCCC Presents on 12/3/25 at the Evercore Healthcare Conference. $VERA Presents on 12/3/25 at the Citi Healthcare Conference"
X Link 2025-12-02T00:09Z [---] followers, [---] engagements

"Biotech LONG's should really check out the following companies. A great day today: $STRO: +20% $CCCC: +14% $MGX: +14% $VERA: +13% @_Biotech_iQ @dough @A_May_MD @adamfeuerstein @seedy19tron @Biotechnerd1"
X Link 2025-12-03T21:17Z [---] followers, [---] engagements

"Money flowing in from AI/Tech to Biotech which is why the XBI is not falling like other indexes. Biotech will rebound very soon. $KYTX Started a large position on the stupid selloff. $CCCC: Added shares $STRO: Added shares $ACET: Added shares $WVE: Added/Doubled my Shares"
X Link 2025-12-17T22:03Z [---] followers, [---] engagements

"$VERA: All-time high of $51.72 reached today on the heals of several analyst upgrades this morning. JP Morgan: Upgrade to $96/share Goldman Sachs: Upgrade to $95/share BofA: Upgrade to $66/share Numerous other upgrades in the past few weeks with PT's generally $80-$100/share"
X Link 2025-12-19T18:28Z [---] followers, [---] engagements

"$KYTX: A Director and a fund buy over [------] shares of the stock on the open market a few days ago. Very bullish"
X Link 2025-12-23T11:20Z [---] followers, [---] engagements

"@doepke_michel No mention of $VERA $VTYX or $WVE Most of these are on my list with much higher probabilities of acquisition than the ones you list here IMO"
X Link 2025-12-28T19:16Z [---] followers, [----] engagements

"Been taking advantage of some year-end profit-taking (selling) to add to a few of my positions with $CCCC $CLYM $TECX $VERA and $GOSS. Fully expecting biotech stocks to come roaring back after January 1"
X Link 2025-12-30T16:23Z [---] followers, [---] engagements

"@BOSSTRADING0 $VERA $TECX $STRO and $CLYM"
X Link 2026-01-02T01:17Z [---] followers, [---] engagements

"@doepke_michel $VERA"
X Link 2026-01-02T22:57Z [---] followers, [---] engagements

"@Biotenic @Biotenic the $VERA PDUFA is expected around July or so"
X Link 2026-01-05T01:34Z [---] followers, [---] engagements

"$VTYX halted $LLY in advanced talks to buy Ventyx Biosciences in more than $1 billion deal WSJ reports"
X Link 2026-01-06T20:58Z [---] followers, [---] engagements

"@Biotech2k1 $TECX $ANNX"
X Link 2026-01-07T01:18Z [---] followers, [---] engagements

"$ANNX: +14% today so far"
X Link 2026-01-13T19:52Z [---] followers, [--] engagements

"$CCCC: +10% today so far"
X Link 2026-01-13T19:54Z [---] followers, [--] engagements

"$VERA Highlights from #JPM26. (part 1) -PDUFA date 7/7/26. Priority review awarded. -Investigating atacicept in [--] other diseases -1st Dual BAFF/APRIL inhibitor. -Drug stopped Kidney Function/EGFR Slope decline. -Sales Leadership in place. Now hiring [--] sales reps"
X Link 2026-01-13T22:56Z [---] followers, [---] engagements

"You should check out this presentation when it's posted @Biotech2k1 @BOSSTRADING0 @semodough. $VERA may be targeting [--] other indications in autoimmune diseases. This one is for the long haul"
X Link 2026-01-13T23:05Z [---] followers, [---] engagements

"$BIIB: Regarding BD management noted interest in "one more near-term growth asset something end of Phase III/early commercial" and a continued commitment to rare immunology. @JPM26:"
X Link 2026-01-14T00:07Z [---] followers, [---] engagements

"$CCCC: By year-end 2026: -Earn research milestones/licensing fees from collaborations with Merck KGaA Darmstadt Germany Roche and Biogen. -Deliver at least one development candidate to a collaboration partner. -Advance existing collaborations toward key milestones"
X Link 2026-01-14T12:55Z [---] followers, [---] engagements

"@Andre_AGTC $VERA is down about 15% in the past month. Great time to add to positions with a PDUFA by July. Most financial firms have Price Targets of $75-$100+/share. With $VERA already looking at other targets for their drug FDA approval is highly likely and it is a buyout target"
X Link 2026-01-20T16:59Z [---] followers, [---] engagements

"$VERA is down about 15% in the past month. Great time to add to positions with a PDUFA by July. Most financial firms have Price Targets of $75-$100+/share. With $VERA already looking at other targets for their drug FDA approval is highly likely and it is a buyout target"
X Link 2026-01-20T17:00Z [---] followers, [---] engagements

"$ANNX: New 52-Week High. +11% so far today on no news"
X Link 2026-01-21T20:51Z [---] followers, [---] engagements

"So basically $SNY blew their opportunity to acquire $VTYX. Fantastic reporting by UBS here. My repost comes in multiple comments. Proxy filing for the proposed acquisition of VTYX by LLY reveals that (1) SNY declined to exercise its ROFN on VTYX's VTX3232 and"
X Link 2026-01-25T18:24Z [---] followers, [---] engagements

"@PikaBulb @GeneInvesting Seems like the selloff in advance of the $GOSS February Phase [--] Readout will follow suit with a huge run. Current Price: $2.55 Price Targets Oppenheimer: $12 Cantor: Strong Buy UBS: $9 Scotia Bank: $11"
X Link 2026-01-27T16:22Z [---] followers, [---] engagements

"Tee Up $GOSS: Seems like the selloff in advance of the February Phase [--] Readout will follow suit with a huge run. Current Price: $2.55 Price Targets: Oppenheimer: $12 UBS: $9 Scotia Bank: $11 Cantor: Strong Buy"
X Link 2026-01-27T16:24Z [---] followers, [---] engagements

"@GeneInvesting @Biotech2k1 I have no skin in the game for $NTLA but interesting that Wells Fargo has a PT of $12. The share price action today on this news is not encouraging"
X Link 2026-01-28T02:21Z [---] followers, [---] engagements

"@semodough This is the one to watch in the VERY near term. Huge short interest high PTs from the analysts and a big catalyst coming possibly in days"
X Link 2026-01-28T03:11Z [---] followers, [--] engagements

"$VERA announces Chief Commercial Officer. $VERA is a strong buy at current levels ($47) with an Accelerated Approval PDUFA date of July [--]. This one will hit Cantor: $100 Evercore: $97 JPM: $95 Goldman: $95 HC Wainright: $90 https://finance.yahoo.com/news/vera-therapeutics-announces-appointment-matt-123000128.html https://finance.yahoo.com/news/vera-therapeutics-announces-appointment-matt-123000128.html"
X Link 2026-01-28T13:30Z [---] followers, [---] engagements

"$VERA Highlights from #JPM26. -Announced Chief Commercial Officer on 1/28/26. -Now hiring [--] sales reps. -Accelerated Approval. PDUFA date 7/7/26. -1st Dual BAFF/APRIL inhibitor. -Stopped EGFR Slope decline. -Investigating atacicept in [--] other diseases"
X Link 2026-01-28T13:34Z [---] followers, [---] engagements

"$GOSS: Gossamer Bio files automatic mixed securities shelf. I view this as very POSITIVE considering they have a very important Phase [--] readout days away. We usually see money being raised after a big rally on really good news. THIS IS A SIGN THE READOUT WILL BE VERY POSITIVE"
X Link 2026-01-28T21:13Z [---] followers, [----] engagements

"@avidresearch Pretty telling sign that a positive catalyst that will skyrocket the share price of $GOSS and cause a huge short squeezeis only days away"
X Link 2026-01-30T04:02Z [---] followers, [---] engagements

"Pretty telling sign that a positive catalyst that will skyrocket the share price of $GOSS and cause a huge short squeezeis only days away"
X Link 2026-01-30T04:02Z [---] followers, [----] engagements

"Think well see more dough @semodough This is a pretty informative clue"
X Link 2026-01-30T04:12Z [---] followers, [---] engagements

"@seedy19tron Just doubled my position in $GOSS. Disagree with your short position but we shall see. The research from Barclay's (1/27 with a $9 PT) HC Wainwright (1/22 with a $10 PT) and Piper Sandler (1/12 with a $15 PT) are all very supportive of a positive readout and quite compelling"
X Link 2026-01-30T19:30Z [---] followers, [----] engagements

"Great opportunity to grab very cheap shares of $VERA prior to approval of Atacicept for IGaN with a July [--] PDUDA. I see $VERA as a good M&A target. VERA usually trades around $48-52/share and should begin to run up soon. Numerous PTs in the $75-$100 range"
X Link 2026-02-01T07:40Z [---] followers, [--] engagements

"$KYTX flying under the radar and a good time to accumulate shares. Leerink Wells Fargo Morgan Stanley all with a 200-300% return forecasted from here. Cash runway into [----] is expected to fully fund SPS BLA filing 1H26 with commercial launch and a Phase [--] gMG trial"
X Link 2026-02-01T07:56Z [---] followers, [---] engagements

"$TECX: Up 15% so far today. Sleeping giant - A lot of big things in the pipeline. Price Targets: $60: Truist $80: Oppenheimer $101: Well Fargo $76: Raymond James $88: LifeSci Capital $85: Mizuho"
X Link 2026-02-02T15:35Z [---] followers, [---] engagements

"@semodough Thank you. Huge for $TECX No one knows about this March [----] article yet. Proves $LLY's trial failure was a one-off & validates $TECX. Wells Fargo: Shares go 25%+ on a positive AZN readout & 5-10x on a positive Phase [--] TX45 readout. Hold on tight https://www.cell.com/molecular-therapy-family/advances/fulltext/S3117-387X(26)00009-1 https://www.cell.com/molecular-therapy-family/advances/fulltext/S3117-387X(26)00009-1"
X Link 2026-02-02T16:21Z [---] followers, [---] engagements

"Huge for $TECX No one knows about this March [----] article yet. Proves $LLY's trial failure was a one-off & validates $TECX. Wells Fargo: Shares go 25%+ on a positive AZN readout & 5-10x on a positive Phase [--] TX45 readout. Hold on tight https://www.cell.com/molecular-therapy-family/advances/fulltext/S3117-387X(26)00009-1 https://www.cell.com/molecular-therapy-family/advances/fulltext/S3117-387X(26)00009-1"
X Link 2026-02-02T16:22Z [---] followers, 12.8K engagements

"@avidresearch Good point and agree. I'm only pointing out what Wells Fargo said. I think it would fly 50-100% higher from current levels"
X Link 2026-02-02T20:30Z [---] followers, [---] engagements

"$TECX: No one is selling. Wells Fargo expected a 25%+ run in share price AFTER positive AZN3427 news. It hasn't even been released yet and we're up almost 30% in [--] days. Wells previously noted in their research that there's a very large short interest in $TECX. Get ready"
X Link 2026-02-03T15:29Z [---] followers, [---] engagements

"$WVE: Listening to the Cantor Fitzgerald webinar with $WVE management. WV-007 data coming up is very impressive and they're excited. Confirmed it will be in Q1 [----]. -Great differentiated data. -Accelerating higher BMI fully enrolled study w/ [---] patients"
X Link 2026-02-04T18:35Z [---] followers, [---] engagements

"$WVE: Part [--] Cantor webinar. -WVE-007: Exploring strategic collaborations. -WVE-006: CEO confirmed $GSK did NOT see new data before giving full rights to $WVE. GSK continues to support $WVE. -INHBE may be studied in other therapeutic treatments like MASH"
X Link 2026-02-04T19:03Z [---] followers, [---] engagements

"$GOSS Part [--]. H.C. Wainwright (Buy $10 PT) Barclays (Overweight $9) Cantor Fitzgerald (Overweight) Piper Sandler (Buy $15) Oppenheimer ($12) PROSERA data (Feb 2026) could drive 3-5x upside if positive; M&A speculation high given management track record and PAH market ($6B+)"
X Link 2026-02-07T21:22Z [---] followers, [---] engagements

"$GOSS Institutions/Hedge funds: Octagon Capital: 7.4% (16.7M shares). New Enterprise: 7.8% (17.6M shares). BlackRock: 6.0% (13.5M shares). Perceptive Advisors: 3.8M shares (2%). Rock Springs Capital: 3.3M shares (1.7%). Total funds/institutions: [---] (up 14% QoQ)"
X Link 2026-02-07T21:26Z [---] followers, [---] engagements

"$GOSS: Seralutinib demonstrates in vitro reduction of vascular inflammatory drivers underlying pulmonary hypertension. Zhaoqing Ding Elisa Schiavi Silvia Cantoni European Respiratory Journal [----] 66(suppl 69): PA1039"
X Link 2026-02-07T21:52Z [---] followers, [----] engagements

"$AZN financials and pipeline update on February [--]. $TECX: No one is selling. Wells Fargo expected a 25%+ run in share price AFTER positive AZN3427 news. It hasn't even been released yet and we're up almost 30% in [--] days. Wells previously noted in their research that there's a very large short interest in $TECX. Get ready $TECX: No one is selling. Wells Fargo expected a 25%+ run in share price AFTER positive AZN3427 news. It hasn't even been released yet and we're up almost 30% in [--] days. Wells previously noted in their research that there's a very large short interest in $TECX. Get ready"
X Link 2026-02-09T02:23Z [---] followers, [---] engagements

"@A_May_MD Overall while the read-through validates concerns about relaxin-class efficacy (LLY AZD3427s inefficacy) TX45s design dosing and targeted approach offer a plausible path to success potentially viewing the market dip as an overreaction similar to post-Lilly events"
X Link 2026-02-10T11:47Z [---] followers, [---] engagements

"@A_May_MD I be doing some additional research to see if I will double down and purchase more shares on this selloff. But I will not be selling shares today and wouldnt be surprised at all if we see some buying on the dip"
X Link 2026-02-10T11:49Z [---] followers, [---] engagements

"$TECX: While the read-through validates concerns about relaxin-class efficacy (LLY AZD3427) TX45s design dosing and targeted approach offer a plausible path to success potentially viewing the market dip as an overreaction similar to post-Lilly events"
X Link 2026-02-10T11:50Z [---] followers, [---] engagements

"@monaco_biotech Not selling May be buying more shares today"
X Link 2026-02-10T11:52Z [---] followers, [--] engagements

"Wells Fargo note this morning says the pullback $TECX is overdone since we dont know details and the TX-45 trial could be differentiated. AZN news still a concern. Wells Fargo views the magnitude of the pullback as if the TX-45 trial itself failed. Maintains a $101 Price Target"
X Link 2026-02-10T15:23Z [---] followers, [---] engagements

"$TECX. Recall IF the Phase [--] TX45 readout this year is positive Wells Fargo expects a 5-10x run in share price. This was based on research in November. With AZN competition out of the way its hard not to consider loading up shares at these levels for an insane 10x+ return"
X Link 2026-02-10T15:54Z [---] followers, [---] engagements

"Even the CFO of $TECX took advantage of the panic selloff. Big things coming for $TECX soon for [--] different indications. If Prosera trial readout is positive Wells Fargo expects a 6-10x rise in share price (Price Target $101). $TECX CFO acquires $120k at open market $XBI $IBB Catalyst/readout [----] Phase [--] RXFP1 Agonist (TX45 Fc-relaxin) Heart Failure with Preserved Ejection Fraction (HFpEF) Phase [--] Group [--] Pulmonary Hypertension https://t.co/L4MXW6iXPs $TECX CFO acquires $120k at open market $XBI $IBB Catalyst/readout [----] Phase [--] RXFP1 Agonist (TX45 Fc-relaxin) Heart Failure with Preserved"
X Link 2026-02-12T08:23Z [---] followers, [---] engagements

"$VERA's upcoming FDA Approval/commercial launch will lead to much higher sales than the street is expecting. Otsuka revenue forecast this AM is 2x expectations. $VERA is an APRIL/BAFF inhibitor with superior EGFR data (Otsuka targets only BAFF). $VERA is a STRONG BUY. PT $70-$100"
X Link 2026-02-13T13:24Z [---] followers, [---] engagements

"Supplies for #HURRICANE victims stolen from church #FWCWeather http://gpwx.news/wxh6e http://gpwx.news/wxh6e"
X Link 2017-09-11T22:45Z [---] followers, [--] engagements

"Texas company builds new oyster reef after #HURRICANE Harvey devastated population #FWCWeather http://gpwx.news/beqc1 http://gpwx.news/beqc1"
X Link 2018-07-16T23:00Z [---] followers, [--] engagements

"Magnitude [---] #EARTHQUAKE strikes Indonesia prompting #TSUNAMI warning #FWCWeather http://gpwx.news/6529g http://gpwx.news/6529g"
X Link 2018-08-05T13:15Z [---] followers, [--] engagements

"More People See Climate Change In Record Floods And Extreme #WEATHER. Will That Mean More Action #FWCWeather http://gpwx.news/8317k http://gpwx.news/8317k"
X Link 2019-06-08T10:19Z [---] followers, [--] engagements

"Keeping it real with a tough forecast NWS Nashville [---] PM CDT Jul [--] [----] I dont usually do this but Ive sat here for [--] minutes trying to decide what to type. My struggles revolve around the lack of any consistency between models when it comes to storm development 1/2"
X Link 2023-07-18T08:29Z [---] followers, [---] engagements

"Daily dose of weather humor: Tornado report near the Charleston SC area. According to the NWS video was used to confirm that the car was hi"
X Link 2023-08-31T06:02Z [---] followers, [---] engagements

"@hurricanetrack The Euro did terribly early on with Idalia. I see a slightly stronger ridge and slightly weaker Great Lakes trough in some of the latest models. Will be interesting to see if that trend (and a further west track) occurs. NOAA Recon and additional soundings start tomorrow"
X Link 2023-09-07T01:02Z [---] followers, [---] engagements

"Happy 1st Day of School This cloud-to-ground (CG) lightning bolt struck this tree (I took pictures of both) that landed on Guilderland High School in New York causing minor damage. A microburst with 50-60 mph winds and nickel sized hail also occurred"
X Link 2023-09-07T22:48Z [---] followers, [---] engagements

"Amazing photograph of the northern lights at the National Weather Service in Riverton Wyoming this morning. Its going to be an exciting [--] hours in the northern US and Canada for aurora borealis. Photo: NWS Riverton"
X Link 2023-11-05T12:47Z [---] followers, [---] engagements

"@Giants New York Giants New Years resolution: Learn how to tackle. Pathetic"
X Link 2023-12-26T00:16Z [---] followers, [--] engagements

"Not too often do you see a Severe Thunderstorm Warning in Puerto Rico. TJUA - Super-Res Reflectivity [--] 6:39 PM Super-Res Velocity [--] 6:34 PM #prwx"
X Link 2024-05-02T22:41Z [---] followers, [--] engagements

"Looks like an enormous tornado over Robert Lee (apparently a town in Texas). Just the good ole boys never meaning no harm.beats all the standing corn and causes trouble with the law since the minute it formed. KSJT - Super-Res Reflectivity [--] 5:37 PM Super-Res Velocity 1"
X Link 2024-05-03T21:39Z [---] followers, [---] engagements

"Heavy damage from Hurricane Beryl on the beautiful Caribbean island of Martinique. https://youtu.be/UHEK-4FWXzssi=_ZPdi5hjGZPCaSp2 https://youtu.be/UHEK-4FWXzssi=_ZPdi5hjGZPCaSp2"
X Link 2024-07-03T01:54Z [---] followers, [---] engagements

"@RLazear @btangyWx Funny. I was a couple of towns over in Waterville and took these. Im going to be processing a time lapse I took of the supercell with my GoPro"
X Link 2024-07-11T02:37Z [---] followers, [---] engagements

"G75 MPH on the OHare ASOS. WOW. Going to be a lot of flight delays and cancellations overnight KORD 160251Z 32024G50KT [--] 1/2SM R10L/3500VP6000FT +TSRA BR SQ BKN019CB BKN040 OVC140 22/21 A2972 RMK AO2 PK WND 26065/0239 RAB38 TSB26 PRESRR SLP060 CONS LTGCGIC OHD"
X Link 2024-07-16T03:03Z [---] followers, [---] engagements

"This week we had the opportunity of a lifetime to take a private tour of The White House. We arrived for our tour a few hours after President Biden arrived at the White House and the same day that Prime Minister Netanyahu arrived in Washington. What an experience"
X Link 2024-07-27T14:29Z [---] followers, [--] engagements

"Secret Service cleared the rest of our photos. Heres one from the Rose Garden at The White House. Biden was in his residence behind that far door. What an epic visit"
X Link 2024-08-06T03:02Z [---] followers, [--] engagements

"@POTUS Waityoure actually not on vacation and AT The White House"
X Link 2024-09-11T03:22Z [---] followers, [--] engagements

"Hey @MTV : Completely tasteless that MTV has their VMAs tonight and so many celebs celebrate. Red carpet After parties Who the F cares what youre wearing. On 9/11 Disgraceful"
X Link 2024-09-12T01:14Z [---] followers, [---] engagements

"BREAKING NEWS: Magnitude [---] earthquake just hit the Cayman Islands. Tsunami warning going up for most of the Caribbean Islands. Not sure about FL or the gulf coast yet. https://earthquake.usgs.gov/earthquakes/eventpage/us7000pcdl/executiveutm_medium=email&utm_source=ENS&utm_campaign=realtime https://earthquake.usgs.gov/earthquakes/eventpage/us7000pcdl/executiveutm_medium=email&utm_source=ENS&utm_campaign=realtime"
X Link 2025-02-08T23:54Z [---] followers, [---] engagements

"@GenFlynn Take a deep breath General. Not everything needs to be a conspiracy theory or extravagant unsupported assumptions. Its hot and very humid in Texas. When rare conditions like this align just right which was the case here you get terrible flash flooding. So sad"
X Link 2025-07-06T16:58Z [---] followers, [---] engagements

"#HURRICANE Ophelia now a major storm barreling toward Ireland #FWCWeather http://gpwx.news/5138k http://gpwx.news/5138k"
X Link 2017-10-14T16:29Z [---] followers, [--] engagements

"$TECX: Management buy $175000 of stock on the open market"
X Link 2026-02-15T09:02Z [---] followers, [--] engagements

"RT @semodough: $GOSS @avidresearch am I reading that right BLACKROCK added [--] million as yesterday bringing there total to [--] million $GOS"
X Link 2026-02-13T15:26Z [---] followers, [--] engagements

"$GOSS @avidresearch am I reading that right BLACKROCK added [--] million as yesterday bringing there total to [--] million $GOSS shares $GOSS interesting take "distribution-of-outcomes event rather than a binary one" $GOSS interesting take "distribution-of-outcomes event rather than a binary one""
X Link 2026-02-13T13:59Z 42.5K followers, 12.3K engagements

"$GOSS interesting take "distribution-of-outcomes event rather than a binary one" $GOSS HCW deep dive out Key Takeaways PROSERA is not a binary eventinterpretability will drive the rerate. Effect size placebo behavior and coherence across endpoints will matter as much as statistical significance. The most important risk is placebo variability not $GOSS HCW deep dive out Key Takeaways PROSERA is not a binary eventinterpretability will drive the rerate. Effect size placebo behavior and coherence across endpoints will matter as much as statistical significance. The most important risk is placebo"
X Link 2026-02-10T13:20Z 12K followers, 15K engagements

"$VERA's upcoming FDA Approval/commercial launch will lead to much higher sales than the street is expecting. Otsuka revenue forecast this AM is 2x expectations. $VERA is an APRIL/BAFF inhibitor with superior EGFR data (Otsuka targets only BAFF). $VERA is a STRONG BUY. PT $70-$100"
X Link 2026-02-13T13:24Z [---] followers, [---] engagements

"$LEGN quietly making a big push into in vivo Car-T: LVIVO-TaVec100 (CD19 x CD20) LVIVO-TaVec200 (GPRC5D) LVIVO-TaVec400 (target undisclosed) .all recently entered human trials"
X Link 2026-02-12T20:28Z 31.8K followers, [----] engagements

"New in vivo Car-T player NCI licensing patent for an anti-CD19 in vivo Car-T for autoimmune disease to $KYTX - https://public-inspection.federalregister.gov/2026-02907.pdf https://public-inspection.federalregister.gov/2026-02907.pdf"
X Link 2026-02-12T13:56Z 31.8K followers, [----] engagements

"Even the CFO of $TECX took advantage of the panic selloff. Big things coming for $TECX soon for [--] different indications. If Prosera trial readout is positive Wells Fargo expects a 6-10x rise in share price (Price Target $101). $TECX CFO acquires $120k at open market $XBI $IBB Catalyst/readout [----] Phase [--] RXFP1 Agonist (TX45 Fc-relaxin) Heart Failure with Preserved Ejection Fraction (HFpEF) Phase [--] Group [--] Pulmonary Hypertension https://t.co/L4MXW6iXPs $TECX CFO acquires $120k at open market $XBI $IBB Catalyst/readout [----] Phase [--] RXFP1 Agonist (TX45 Fc-relaxin) Heart Failure with Preserved"
X Link 2026-02-12T08:23Z [---] followers, [---] engagements

"$TECX CFO acquires $120k at open market $XBI $IBB Catalyst/readout [----] Phase [--] RXFP1 Agonist (TX45 Fc-relaxin) Heart Failure with Preserved Ejection Fraction (HFpEF) Phase [--] Group [--] Pulmonary Hypertension"
X Link 2026-02-11T23:11Z [----] followers, 14.1K engagements

"$TECX. Recall IF the Phase [--] TX45 readout this year is positive Wells Fargo expects a 5-10x run in share price. This was based on research in November. With AZN competition out of the way its hard not to consider loading up shares at these levels for an insane 10x+ return"
X Link 2026-02-10T15:54Z [---] followers, [---] engagements

"Wells Fargo note this morning says the pullback $TECX is overdone since we dont know details and the TX-45 trial could be differentiated. AZN news still a concern. Wells Fargo views the magnitude of the pullback as if the TX-45 trial itself failed. Maintains a $101 Price Target"
X Link 2026-02-10T15:23Z [---] followers, [---] engagements

"$TECX: While the read-through validates concerns about relaxin-class efficacy (LLY AZD3427) TX45s design dosing and targeted approach offer a plausible path to success potentially viewing the market dip as an overreaction similar to post-Lilly events"
X Link 2026-02-10T11:50Z [---] followers, [---] engagements

"$AZN financials and pipeline update on February [--]. $TECX: No one is selling. Wells Fargo expected a 25%+ run in share price AFTER positive AZN3427 news. It hasn't even been released yet and we're up almost 30% in [--] days. Wells previously noted in their research that there's a very large short interest in $TECX. Get ready $TECX: No one is selling. Wells Fargo expected a 25%+ run in share price AFTER positive AZN3427 news. It hasn't even been released yet and we're up almost 30% in [--] days. Wells previously noted in their research that there's a very large short interest in $TECX. Get ready"
X Link 2026-02-09T02:23Z [---] followers, [---] engagements

"$TECX: No one is selling. Wells Fargo expected a 25%+ run in share price AFTER positive AZN3427 news. It hasn't even been released yet and we're up almost 30% in [--] days. Wells previously noted in their research that there's a very large short interest in $TECX. Get ready"
X Link 2026-02-03T15:29Z [---] followers, [---] engagements

"$LEGN ($17/sh): Partnership with JNJ. Consistent durable efficacy and particularly compelling outcomes for Carvykti when used in patients' multiple myeloma treatment journey. PTs: Barclays ($80) HCW ($50) Cowan ($26) Oppenheimer ($75) MS:($50). s https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-present-carvyktir-data-2026-tandem-meetings https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-present-carvyktir-data-2026-tandem-meetings"
X Link 2026-02-09T02:19Z [---] followers, [---] engagements

"$GOSS: Seralutinib demonstrates in vitro reduction of vascular inflammatory drivers underlying pulmonary hypertension. Zhaoqing Ding Elisa Schiavi Silvia Cantoni European Respiratory Journal [----] 66(suppl 69): PA1039"
X Link 2026-02-07T21:52Z [---] followers, [----] engagements

"$GOSS Institutions/Hedge funds: Octagon Capital: 7.4% (16.7M shares). New Enterprise: 7.8% (17.6M shares). BlackRock: 6.0% (13.5M shares). Perceptive Advisors: 3.8M shares (2%). Rock Springs Capital: 3.3M shares (1.7%). Total funds/institutions: [---] (up 14% QoQ)"
X Link 2026-02-07T21:26Z [---] followers, [---] engagements

"$GOSS Part [--]. H.C. Wainwright (Buy $10 PT) Barclays (Overweight $9) Cantor Fitzgerald (Overweight) Piper Sandler (Buy $15) Oppenheimer ($12) PROSERA data (Feb 2026) could drive 3-5x upside if positive; M&A speculation high given management track record and PAH market ($6B+)"
X Link 2026-02-07T21:22Z [---] followers, [---] engagements

"Theres a lot of short-selling occurring with $GOSS prior to an enormous binary event/readout in the next couple of weeks. I suspect well see a wave of buying begin soon. Many positive research reports support a positive readout with much higher results any Price Targets"
X Link 2026-02-07T04:37Z [---] followers, [----] engagements

"$WVE: Part [--] Cantor webinar. -WVE-007: Exploring strategic collaborations. -WVE-006: CEO confirmed $GSK did NOT see new data before giving full rights to $WVE. GSK continues to support $WVE. -INHBE may be studied in other therapeutic treatments like MASH"
X Link 2026-02-04T19:03Z [---] followers, [---] engagements

"$WVE: Listening to the Cantor Fitzgerald webinar with $WVE management. WV-007 data coming up is very impressive and they're excited. Confirmed it will be in Q1 [----]. -Great differentiated data. -Accelerating higher BMI fully enrolled study w/ [---] patients"
X Link 2026-02-04T18:35Z [---] followers, [---] engagements

"Huge for $TECX No one knows about this March [----] article yet. Proves $LLY's trial failure was a one-off & validates $TECX. Wells Fargo: Shares go 25%+ on a positive AZN readout & 5-10x on a positive Phase [--] TX45 readout. Hold on tight https://www.cell.com/molecular-therapy-family/advances/fulltext/S3117-387X(26)00009-1 https://www.cell.com/molecular-therapy-family/advances/fulltext/S3117-387X(26)00009-1"
X Link 2026-02-02T16:22Z [---] followers, 12.8K engagements

"Research paper: "These findings support AZD5462 as a promising novel therapy for chronic heart failure. A phase [--] study of AZD5462 is currently underway in patients with chronic heart failure.""
X Link 2026-02-02T16:23Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

@FWCStocks
/creator/twitter::FWCStocks